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ABSTRACT 
 
CHARACTERIZATION OF PEPTIDE AMPHIPHILE NANOFIBERS 
THEIR INTERACTIONS WITH CHONDROPROGENITOR CELLS AND 
MORPHOLOGICAL ANALYSIS OF TISSUES FROM TRANSGENIC 
ANIMALS 
 
Ayşegül Tombuloğlu 
M.Sc. in Materials Science and Nanotechnology 
July, 2012 
 
Peptide amphiphiles, molecules able to self assemble into three dimensional networks 
resembling to extracellular matrix which is excessive in cartilage tissue, are suitable 
candidates for overcoming cartilage tissue defects and diseases which constitute 
central health problems throughout ages. Understanding developmental processes that 
underlie cartilage formation is also key for regenerating cartilage. In this study, 
peptide amphiphiles were synthesized, their potential for cartilage regeneration was 
investigated and a model for cellular aggregation, which is a central process in 
embryonic cartilage development, was established with chondroprogenitor cells and 
peptide amphiphile scaffolds. On scaffolds, chondroprogenitor cells aggregated 
without requiring any additional bioactive factors as opposed to cells grown without 
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scaffolds. Addition of insulin to the medium enhanced the size of the aggregates 
suggesting scaffolds may be interacting with insulin. Similar to native cartilage 
tissue, collagen II was massively produced in aggregates. GAG-PA which is designed 
to mimic glycosaminoglycans and Glu-PA which only presents glutamic acid were 
used to construct scaffolds with oppositely charged Lys-PA presenting lysine. 
Formation of aggregates was observed regardless of the PAs used. Use of both GAG-
PA and Glu-PA induced larger number of aggregates than only Glu-PA. Differential 
effect of GAG-PA couldn’t be inferred completely and might be investigated in more 
detail.  
In a second part of the study, tissue morphologies of lynx3 null mutant mice were 
studied. Lynx3 is a recently discovered protein belonging to Ly6-superfamily. It is 
expressed mainly within epithelial lining of respiratory, digestive and genital tracts 
and is involved in nicotinic acetylcholine receptor desensitization. In this study, 
morphologies of lynx3 null mice with that of wild type mice were compared to see 
whether lynx3 has a gross effect on the tissues in which it is expressed. Any 
significant difference in the morphologies of lung, trachea and thymus cannot be 
observed. Little variations in esophagus, stomach and female reproductive organ were 
seen, however, it was not clear whether these variations are related to individual 
differences or not and the relevance of the variations with lynx3 expression could not 
be seen clearly. More detailed analysis of tissues may provide additional insight to 
understand function of lynx3 and the cholinergic mechanisms within various tissues.  
Short peptides able to pass cell membrane and deliver genes into cells are outstanding 
alternatives to virus based transfection systems. In the third part of the study, peptide 
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amphiphiles designed to mimic the natural polycationic proteins through forming 
nanofibers which exhibit positively charged residues at high density, were 
synthesized. Peptide amphiphiles could form stable complexes with DNA, through 
neutralization of charges and formation of hydrogen bonds. However, efficient 
transfection of the gene couldn’t be provided by any complexes in vitro. The study 
presents primary results upon which more detailed investigation can be built.  
Keywords: Cartilage, peptide amphiphiles, aggregation, chondroprogenitor cells, 
chondrogenic differentiation, lynx3, cell penetrating peptides. 
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ÖZET 
 
PEPTİT AMFİFİL NANOFİBERLERİNİN KARAKTERİZASYONU, 
KONDROSİT ÖNCÜLÜ HÜCRELERLE ETKİLEŞİMLERİ VE 
TRANSGENİK HAYVANLARA AİT DOKULARIN MORFOLOJİK 
ANALİZİ 
 
Ayşegül Tombuloğlu 
Malzeme Bilimi ve Nanoteknoloji Programı, Yüksek Lisans 
Tez Yöneticisi: Yard. Doç. Dr. Ayşe Begüm Tekinay 
Temmuz, 2012 
 
Kıkırdak dokusunda çok yoğun bulunan hücrelerarası matrise benzer üç boyutlu ağlar 
kurabilen peptit amfifiller, çağlar boyu çözümsüz kalmış temel sağlık sorunları teşkil 
eden kıkırdak dokusu hasarları ve hastalıklarının üstesinden gelmeye uygun 
adaylardır. Kıkırdak dokusu oluşumunun altında yatan temel süreçleri anlamak da 
kıkırdak rejenerasyonu için kilit öneme sahiptir. Bu çalışmada, biyoaktif peptit 
amfifil nanofiberlerin kıkırdak rejenerasyonuna yönelik potansiyelleri incelenmiştir 
ve kondrosit öncülü hücreler ve peptit amfifillerle embryonik kıkırdak gelişiminde 
merkezi bir süreç olan hücresel toplanma için bir model, oluşturulmuştur. Peptit 
amfifillerin oluşturduğu iskeleler üzerinde hücreler, iskele olmadan kültürlenen 
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hücrelerin tersine, fazladan etken maddelere ihtiyaç duymadan toplanmışlardır. 
Besiyerine insülin eklenmesi, oluşan hücre yığınlarının boyutunu arttırmıştır ki bu 
sonuç insülin ve iskelelerin etkileşiyor olabileceğini akla getirmektedir. Hücre 
yığınlarında, hücreler arası matris ve kollajen II, doğal kıkırdak yapısına benzer 
şekilde büyük miktarlarda üretilmektedir. Glikozaminoglikanlara benzemek üzere 
tasarlanmış GAG-PA, ve yalnızca glutamik asit sergileyen Glu-PA, lizin sergileyen 
zıt yüklü Lys-PA ile iskeleler inşa etmede kullanılmıştır. Hücre yığınlarının oluşumu, 
kullanılan peptit amfifillere bağlı olmaksızın gözlemlenmiştir. İskelelerde GAG-PA 
ve Glu-PA’nın birlikte kullanımı yalnızca Glu-PA’nın kullanıldığı iskelelere göre 
daha fazla hücre yığını oluşumu tetiklemiştir. GAG-PA’nın farka neden olan etkisi 
yeterince iyi çözümlenememiş olup daha ayrıntılı araştırılabilir.  
Çalışmanın ikinci kısmında, Lynx3 ifade etmeyen transgenik farelerin doku 
morfolojileri çalışılmıştır. Ly6 üst-ailesine ait olan Lynx3, yakın zamanda keşfedilen, 
bir proteindir. Solunum, sindirim ve üreme kanallarının epitel hattı boyunca ifade 
edilmektedir ve nikotinik asetilkolin reseptörlerinin duyarsızlaştırılmasında görev 
almaktadır. Bu çalışmada, Lynx’3ün ifade edildiği dokularda önemli bir etkisi olup 
olmadığını görmek amacıyla Lynx3’süz (transgenik) farelerin morfolojileri yabani tür 
farelerle karşılaştırılmıştır. Akciğer, trake ve timus dokularında kayda değer herhangi 
bir farka rastlanmamıştır. Özofagus, mide ve dişi üreme organında ufak farklılıklar 
görülse de bunların bireysel farklılıklardan kaynaklanıp kaynaklanmadığı, ve de 
farklılıkların lynx3 proteininin ifadesiyle alakası açıkça görülememektedir. Dokuların 
daha ayrıntılı analizi, lynx3’ün dokulardaki görevinin ve çeşitli kolinerjik 
mekanizmaların anlaşılmasında ışık tutacaktır.  
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Hücre zarını geçebilen ve genleri hücrelere taşıyabilen küçük peptitler, virüs tabanlı 
transfeksiyon sistemlerine karşı belli başlı seçenekler arasında yer almaktadır. 
Çalışmanın üçüncü kısmında, yüksek yoğunlukta artı yüklü aminoasit zincirleri 
sergileyen nanofiberler oluşturma yoluyla doğal polikatyonik proteinlere benzeyecek 
peptit amfifil molekülleri tasarlanmıştır. Peptit amfifiller yüksüzleşme ve hidrojen 
bağları oluşturma yoluyla DNA ile sağlam-kararlı kompleksler meydana 
getirmişlerdir. Fakat in vitro’da, oluşturulan komplekslerden herhangi biri içerdiği 
genin etkin transfeksiyonunu sağlayamamıştır.  
Anahtar kelimeler: Kıkırdak, peptit amfifiller, toplanma-yığın oluşturma, kondrosit 
öncülü hücreler, kondrojenik farklılaşma, lynx3, hücre-delen peptitler  
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CHAPTER 1 
 
BIOACTIVE PEPTIDE AMPHIPHILE NANOFIBERS FOR 
CARTILAGE TISSUE REGENERATION 
 
This work is partially described in the following publication: 
Tombuloglu, A.T.; Guler, M.O.; Tekinay, A.B.; Materials for Articular Cartilage 
Regeneration. Recent Patents on Biomedical Engineering. 2012, X, X-X.  
1.1 Introduction 
Many health problems remaining to be untreatable throughout the human history can be 
overcome by utilizing new biomedical materials. Healing cartilage defects is one of the 
problems causing significant health issue due to low regeneration capacity of the cartilage 
tissue. Scaffolds as three-dimensional functional networks provide promising tools for 
complete regeneration of the cartilage tissue. Diversity of materials and fabrication 
methods give rise to many forms of scaffolds including injectable and mechanically stable 
ones. Various approaches can be considered depending on the condition of cartilage 
defect. A scaffold should maintain tissue function within a short time, and should be 
easily applied in order to minimally harm the body.  
Peptide amphiphiles seem to be promising materials for supporting cartilage regeneration. 
In this study, the aim was to investigate the potential of peptide amphiphiles as materials 
for cartilage tissue regeneration. 
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1.1.1 Biochemical composition of cartilage tissue 
Cartilage tissue has a characteristic environment with high water content. Water content 
of the articular cartilage constitutes about the 70% of the cartilage weight [1]. 
Proteoglycan molecules; the proteins bearing attached carbohydrate chains with high 
negative charge density are the main elements responsible with the high water 
contribution to the tissue. The long carbohydrate chains in the extracellular matrix called 
glycosaminoglycans are crucial for tissue functionality and integrity. Most of the GAGs 
carry negative charges which attract positively charged molecules and this results in 
osmotic pressure driven capture of the water molecules. High amount of water causes the 
tissue to be stiffer and it is very significant for distribution of stresses uniformly 
throughout the tissue. Moreover, GAG molecules act as reservoirs for growth factors and 
they can be essential for proper functioning of growth factor molecules. Aggrecan is the 
most prominent proteoglycan and it contains chondroitin sulfate chains on its protein core. 
Perlecan is another proteoglycan, having attached chondroitin sulfate and heparane sulfate 
on its backbone. Its presence was shown to be required for cartilage tissue formation. 
Decorin, biglycan and fibromodulin are other proteoglycans that are smaller and these are 
important for tissue function and arrangement as they interact with other ECM 
components [2, 3].  
Collagens, especially collagen II, are the most populated proteins in cartilage tissue. They 
are of vital importance for the tissue [4]. Aggrecan, and collagen II, a member of the 
collagen family, are thought to be characteristic markers of cartilage tissue. A 
cartilaginous tissue is usually described as having high collagen II/collagen I ratio and 
high aggrecan content. If the collagen II/ collagen I ratio increases in a mesenchymal stem 
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cell population or if the amount of aggrecan increases, these are considered to be 
indications for differentiation into cartilage tissue [3, 5]. Besides collagen II, other 
members of the collagen family such as collagen VI, IX, X, and XI are also present in the 
cartilage in considerable amounts. Close microenvironment of the chondrocytes is rich in 
collagen VI. Collagen X is generally found in calcified areas [6].  
1.1.2  Cartilage Tissue Engineering 
Unlike many other tissues, articular cartilage does not have sufficient regenerative 
capacity in case of an injury due to i) absence of vasculature, which limits access to blood 
and lymphatic elements and ii) absence of neurons, which isolates the tissue from 
regulatory mechanisms of nervous system. Regenerative response may be possible if 
blood finds a way to reach the defect area from underlying bone to form fibrin matrices 
where cells can proliferate. Chondrocytes are densely covered with extracellular matrix 
and have limited capacity for proliferation and migration to heal the defect in adult 
tissues. Only bone marrow cells can attempt to restore the defect through a fracture in the 
cartilage tissue. Complete regeneration of the cartilage tissue is rarely observed [7]. 
Osteoarthritis is a prevalent joint disorder and is a major cause of cartilage injuries 
affecting mostly individuals over age of 65 [8]. Severe pain, loss of motility and stiffness 
are among its symptoms. Several pharmacological and surgical therapeutic strategies have 
previously been developed for the treatment of osteoarthritis [9]. Utilization of biomedical 
materials, which is a relatively novel approach, is recently being used in surgical 
practices.  
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1.1.2.1 Artificial scaffolds for cartilage tissue engineering 
Scaffold materials can be produced for various purposes depending on the nature of the 
cartilage defect and the surgical procedure that will be utilized. Novel material 
compositions or techniques for scaffold construction can be developed for objectives 
including culturing and differentiation of cells in vitro [10], administration of cells to 
defect site [11], administration and controlled release of biologically active agents such as 
growth factors [12], genes [13] or drugs [12] to the defect site, providing mechanical 
support for cells at the defect site [14], or attracting cells and active factors [15] within the 
defect. A common rationale behind using three-dimensional scaffolds is to enhance 
cellular adhesion and proliferation to form a functional tissue and to allow for transport of 
nutrients and waste (Figure 1). In general, healing a target tissue requires use of an 
appropriate cell source along with a scaffold. For cartilage tissue regeneration, 
chondrocytes or other cells capable of becoming chondrocytes are used as the cell source. 
Chondrocytes, typically exhibit round morphology and express high levels of aggrecan 
and collagen II. In a monolayer culture, chondrocytes lose their phenotype and become 
fibroblast-like cells, whereas three-dimensional scaffolds generally don’t lead to 
dedifferentiation. Fibroblast-like cells are not qualified as chondrocytes to form 
completely functional cartilage tissue [16]. Therefore, a scaffold for cartilage tissue 
regeneration should support the chondrocyte phenotype and synthesis of cartilage 
extracellular matrix.  
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Figure 1. Scaffold as a template for cell adhesion and proliferation. Scaffold provides an extracellular 
matrix like environment for cells at the defect site. Ideally, a scaffold for cartilage regeneration should have 
interconnected pores allowing movement of cells and free diffusion of soluble factors. Cells can sense and 
react to bioactive signals incorporated within the scaffold which results in overall improvement in 
functional tissue formation. 
 
1.1.2.1.1 Basic properties of scaffold forming materials: 
biocompatibility, bioresorption and biodegradability 
As knowledge for interaction of materials with biological elements has expanded, various 
requirements have emerged and they lead to development of enhanced new therapeutic 
approaches. In earlier biomedical materials, major emphasis was on compatibility of 
materials within the body, more prominently on minimal immunogenicity and toxicity. 
Later, well integration of materials to its close biological environment became an 
important issue. Biocompatibility involves both the ability of the scaffold to be well 
integrated to its biological environment and its constituent cells, in addition to not causing 
any undesirable immunogenic responses or toxic outcomes [17]. Biocompatibility is 
generally considered on basis of individual materials rather than devices composed of 
processed materials. However, it would be better to assess the biocompatibility of devices 
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in their complete forms since surface characteristics and architecture of devices may lead 
to undesired effects [18].  
Hydrophilicity of a biomaterial is a key parameter affecting cell adhesion and 
proliferation properties, which are important for integration of the material within the 
surrounding tissue. In some studies, altering hydrophilicity was used for improving 
biocompatibility of materials. For example, by combining hydrophilic blocks within 
polymers, better cell adherence, and improved biocompatibility were obtained [19]. In 
another patent, a method for increasing the hydrophilicity of tissue constructs was 
described. Gas-clustered ion beam irradiation was used for rendering tissue constructs 
prone to cell adhesion and growth [20]. Blending natural biopolymers is another way to 
improve hydrophilicity for better cell adhesion and proliferation [21].  
Scaffolds that are composed of natural materials are generally biocompatible with similar 
hydrophilic content and chemical cues with cartilage microenvironment. On the other 
hand, chemical production processes, additives or immunogenicity of these materials can 
be problematic. Cross-linking agents and chemical modifications can decrease 
biocompatibility due to cytotoxic effects [10]. To avoid possible harmful effects, less 
toxic or non-toxic cross-linking agents might be preferred. An example of such cross-
linking agents is tripolyphoshate, which was offered for producing biocompatible chitosan 
nanoparticles [22]. Succinimydylated polyethylene glycol synthesized as a cross-linking 
agent is able to carry out cross-linking at physiological conditions and has low 
cytotoxicity [23]. A series of alternative techniques involving mixing basic components of 
cartilage extracellular matrix under controlled conditions comprise a way to achieve 
cartilage like matrices. These techniques, collectively called as self organization methods, 
do not require the use of any organic solvents or cross-linking reagents [24].  
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Immunogenicity risk is especially high for tissue materials obtained from other species. 
Materials of interspecies origin should be totally purified from immunoreactive 
components, particularly alpha-gal epitope on cells of non-primate organisms, which are 
known to lead to severe immune reactions. A way of eliminating immunogenicity of non-
human extracellular matrix is to treat the matrices with galactosidases after destructing 
cells through lysing and/or gamma irradiation [25]. Decellularization of extracellular 
matrix obtained from alpha 1,3 galactosyltransferase deficient organisms also results in 
loss of immunogenic response to a great extent [26]. Natural polymers as a scaffold 
material are generally regarded as less immunogenic than synthetic polymers. However, 
enzymatic treatment may be required to remove immunogenic fragments within proteins 
[27] and filtering may be essential to remove endotoxins, which may induce inflammation 
[28]. Culturing constructed scaffolds within an inner cavity of the body is a way of 
immune conditioning to prevent rejection of the scaffold [29].  
Development of bioresorbable materials has been desired in applications for replacement 
of material with newly forming tissue. Bioresorbability and biodegradability are similar 
terms; biodegradability is breakdown of macromolecules to smaller subunits; and 
bioresorbability is elimination of the subunits from the body [30]. Bioresorbability is 
important, since degradation products may accumulate in the site leading to undesired 
outcomes such as incomplete regeneration of defects. During restoration of cartilage 
defects, implanted matrix should be gradually replaced by healthy cartilage tissue, thus 
materials with very slow degradation rates are not usually preferred. Degradation rate 
should match the rate of new tissue formation, since rapid degradation may lead to loss of 
mechanical support and elimination of cellular extracellular matrix deposition. For 
cartilage regeneration, materials that can stay largely intact for four to ten weeks are 
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preferred [31]. For these reasons, developing methods allowing controlled degradation 
rate of materials is important. For controlled biodegradation, cross-linking density [5, 11, 
26[11, 32], monomer composition [33], or hydrophilicity [34] can be altered. It is also 
possible to control degradation properties of scaffolds by incorporating peptide sequences 
that are susceptible to metalloproteinases. Incorporating peptides particularly specific to 
cleavage by MMP-7 enzymes within scaffolds is a way to make them more degradable as 
the cells differentiate into chondrocyte lineage due to increased activity of MMP-7 
enzymes in the course of chondrogenic differentiation [35]. With suitable modifications, 
optimal degradation rate can be obtained. 
1.1.2.1.2 Biochemical properties of scaffold materials for enhancing 
bioactivity 
Bioactivity is one of the most important aspects protected by various patents. Altering the 
behavior of cells in a way that cells change their gene expression profile, adhere 
specifically, proliferate or differentiate are different means of bioactivity. In the case of 
natural polymers, bioactivity results from the cues already present within the backbone in 
many cases. However, synthetic polymers generally lack the necessary bioactivity. 
Therefore, many patents on synthetic polymers include additional signals enhancing 
bioactivity. Bioactivity enhancing signals can be various epitopes incorporated within the 
polymer backbone or growth factors specific for the tissue. Peptides can be conjugated to 
polymers by using nucleophilic addition chemistry. Strong nucleophiles such as thiol 
groups in cysteine residues and conjugated unsaturated groups such as acrylates provide 
attachment sites between peptides and the polymer backbone [36]. Using growth factors 
with the scaffolds is a common approach for stimulating cells to repair the tissue. Growth 
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factors within TGF-beta superfamily, particularly BMP subtypes, are frequently preferred 
for articular cartilage regeneration [12, 37-39]. Proteins binding to BMPs [40]or genes 
encoding growth factors [13] can also be supplemented for additional bioactivity. For a 
better understanding of bioactivity, natural polymers, synthetic polymers and peptides for 
cartilage regeneration will be described below. 
1.1.2.1.3 Natural polymers 
Natural biomaterials extensively studied as artificial scaffolds involve native cartilage 
extracellular matrix biopolymers including collagen, hyaluronic acid, chondroitin sulfate, 
and other naturally derived polymers (e.g. fibrin, alginate, chitosan and silk). In many 
inventions, hyaluronic acid, chondroitin sulfate and collagen are included within scaffolds 
for promoting cartilage tissue formation within the defect [25, 41]. 
Constituting 15% of the wet cartilage tissue, collagen is a major element of mechanical, 
structural and also biochemical importance. Among a plethora of proteins, collagen II is 
the most abundant protein within articular cartilage tissue. Increased activity of 
collagenases and denaturation of collagen II within cartilage is considered as an indication 
of osteoarthritis [42, 43]. As the most abundant protein in extracellular matrix, collagen is 
a widely used biomaterial for tissue engineering. Patented collagen based scaffolds are 
composed of primarily collagen II or a mixture of collagen I and collagen II [41, 44, 45]. 
Matrices with high collagen I content were reported to be better at attracting cells from 
subchondral tissue within the defect and matrices high collagen II content to be better for 
preventing dedifferentiation of chondrocytes [41]. 
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Collagen is insoluble in cold water due to its secondary structure. When heated, hydrogen 
bonds contributing to secondary structure are broken and collagen gradually becomes 
soluble as denaturation takes place [45]. Collagen can be solubilized with the help of 
pepsin or acetic acid [46, 47]. Treating acidified collagen with enzymes (i.e. pepsin) is 
beneficial for elimination of immunogenic parts of collagen found at protein terminals. 
Atellopeptide is a collagen, which lacks immunogenicity due to enzymatic treatment [27].  
Use of glycosaminoglycans, particularly, hyaluronic acid and chondroitin sulfate within 
scaffolds is common due to their bioactivity. In order to increase bioactivity, 
polysaccharides including glycosaminoglycans can be cross-linked covalently through 
aldehyde groups obtained by oxidizing terminal hydroxides of saccharide units on the 
backbone [48]. Injecting a blend of hyaluronan and chondroitin sulfate salts within a 
cartilage defect provided as much as 94.5% regeneration [49]. Hyaluronic acid is a 
prominent polysaccharide with its chondroprotective, anti-inflammatory, analgesic 
properties and bioactivity [50]. Hyaluronic acid formulations without any modification 
provide insufficient mechanical properties and short retention times within the joint. 
Cross-linking and hydrophobic modification techniques are used for eliminating 
mechanical weakness of hyaluronic acid based scaffolds [51]. A common strategy for 
strengthening the hyaluronic acid scaffolds is esterification of free carboxyl groups of 
glucuronic acid with a variety of alcohols (HYAFF®) [52]. These polymers can vary in 
solubility and mechanical strength depending on the extent of esterification and the type 
of alcohols used. HYAFF® polymers can be processed in order obtain fibers, sponges and 
microspheres [53]. Culturing chondrocytes from various sources within HYAFF11, a 
benzyl ester of hyaluronic acid, was successful in maintaining chondrocyte phenotypes 
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and providing uniform proliferation of cells. In a recent patent, benzyl esters of hyaluronic 
acid and auto-cross-linked hyaluronic acid for three dimensional matrices to encapsulate 
chondrocytes or mesenchymal cells were disclosed. Auto-cross-linked hyaluronic acid is 
obtained by internal esterification in which free carboxyl groups react with hydroxide 
groups to provide intra or inter molecular cross-linkages [54].  
Methods for esterification of hyaluronic acid with hydrophobic organic molecules can be 
used for attachment of insoluble drugs such as rhein on hyaluronic acid backbone 
facilitating intra-articular administration of these drugs. Micrometer sized particles of 
hyaluronic acid were utilized for this purpose. These particles were produced at very low 
temperature and by conjugation to hydrophobic molecules with suitable solvents and 
dialyzing [55]. Esterifying rhein with hyaluronic acid can also be carried out by reacting 
hyaluronic acid with acid chloride of rhein in non-polar aprotic solvents. Esterified 
product which involves rhein, exhibited improved chondroprotective effect compared to 
unmodified hyaluronic acid [56]. Cross-linking hyaluronic acid is possible by 
incorporating diverse functional groups on the hyaluronic acid [57]. Photo-cross-linking is 
another option for enhancing mechanical properties and durability of hyaluronic acid. For 
this purpose, photoreactive reagents like divinylsulfone [58], or propiophenone [59], can 
be inserted on the backbone. Hyaluronic acid has protective role in cartilage degeneration 
and due to this function, it is substantially used in formulations for treating degenerative 
diseases such as osteoarthritis. Molecular weight of hyaluronic acid affects the efficiency 
of protection in a way that protective function of hyaluronic acid gets better with 
increased molecular weight of the polysaccharide [60]. 
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Fibrinogen is a soluble plasma glycoprotein that takes part in blood coagulation cascades. 
Fibrin, the polymeric form of fibrinogen, is a naturally occurring scaffold formed in the 
case of injury to support the local cells [61]. A fibrin scaffold is subject to fibrinolysis, 
and the degradation rate increases with time, which may be beneficial for offering 
flexibility in tissue formation. On the other hand, fast degradation may result in 
production of insufficient amount of extracellular matrix and lack of mechanical stiffness 
[62, 63]. Anti-fibrinolytic agents may be included to provide the scaffold longer-term 
durability [10, 64]. However, anti-fibrinolytic agents decrease the biocompability of the 
scaffolds [65]. Stable fibrin scaffold without any anti-fibrinolytic agents is prepared by 
pouring plasma protein solution, which doesn’t include thrombin, onto molded thrombin 
solution and freeze drying the clotted blend. Implantation of obtained sponge doesn’t 
require completely open surgery and two independent surgical interventions [66]. 
Chitosan, is a linear polysaccharide composed of 1,4 linked β-D-glucosamine residues, 
which exhibit N-acetyl glucosamine groups. Chitosan has a polycationic backbone and it 
can form hydrogels with the negatively charged glycosaminoglycans. Remarkable 
similarity of chitosan with glycosaminoglycans is also an important feature, which may 
facilitate interaction with signaling proteins and provide material for extracellular matrix 
synthesis [67]. The glucosamine residues found in chitosan are reported to be beneficial 
for osteoarthritis treatment [68]. Substantial increase in the amount of chondrocytes upon 
injection of chitosan into the knee articular cavity of rats was demonstrated [69]. 
Chondrocytes cultured on chitosan substrates remained viable and maintained 
chondrocyte phenotype [70]. Behind the biocompatibility and biodegradability; 
antimicrobial properties [71], bioactivity [72] and high abundance of the chitin in nature 
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[73] make chitosan a potential biomaterial for a scaffold to be used in cartilage tissue 
regeneration. Chitosan is obtained by deacetylation of chitin; a structural polysaccharide 
that exist in exoskeletons of invertebrates and fungal cell walls. In such organisms, chitin 
resorption is balanced for both permitting the growth or morphogenesis and supporting 
the organism. Thus, it is both enzymatically degradable and has enough strength for 
providing reinforcement [74]. On the other hand, highly crystalline nature of chitin 
prevents dissolving the material in various solvents. Therefore, chitin is modified to 
obtain easily processable forms. Chitosan is generally produced by a process in which 
chitin is treated with alkaline solutions for the discharge of the acetyl groups. Chitin 
derivative obtained in this way is soluble in aqueous solution of organic acids [75]. 
Lysozyme is the major enzyme responsible for degradation of chitosan in human body. It 
acts primarily on acetylated residues of chitosan. Thus, the degradation rate of chitosan 
scaffolds within the body can be altered with the extent of the deacetylation. Some 
chemical modifications via reactive primary amines throughout the backbone for altering 
degradation rate and mechanical strength are also possible [76, 77]. Use of chitosan as a 
thermo-gelling scaffold material with suitable additives like glucosamine salts [62], or 
glycerolphosphate is also remarkable [78, 79]. 
Alginates are linear polysaccharides similar to chitosan and are synthesized by brown 
algae such as Laminaria hyperborea and lessonia living in shore waters [80]. They are 
linear and unbranched block copolymers of 1,4-linked-D-mannuronic acid (M) and L-
gluronic acid (G) residues. The building blocks may be sequenced in an alternating (i.e. 
GMGMGM) or recurring manner (i.e. MMMMM or GGGGGG) according to the source 
of alginate. Association between carboxylate groups of G blocks and multivalent cations 
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induces gel formation [81]. Alginates are produced at molecular weights between 50-
100,000 kDa. Viscosity and mechanical properties are related to molecular weight 
distribution, concentration and the stochiometric proportion with the cations [82-84]. 
Native cartilage-like tissues were reported to be obtained within alginate hydrogel 
scaffolds [85]. Human mesenchymal stem cells were differentiated to mature 
chondrocytes in three-dimensional alginate gels in the presence of chondrogenic medium 
containing TGF-β3 [86]. 
Silk proteins possess frequently occurring sequences resulting in abundant β-sheet 
structure providing great mechanical strength to the silk fibers. In their natural form, silk 
proteins enclose two protein components called fibroin and sericine. Fibroin is a fibrous 
protein with intense β-sheets constituting the backbone, whereas sericine is an adhesive 
protein that joins together fibroin fibers. Fibroin isolated from silk can be processed to 
obtain porous or fibrous matrices. For obtaining fibroin from natural silk, sericine is 
separated by a process known as degumming. Degumming involves boiling the silk 
within sodium carbonate solution and extensive washing with water. Among patents 
based on silk, salt leaching, freeze drying and gas foaming methods were used for making 
porous scaffolds, and electrospinning with polyethyleneoxide was used for making 
fibrillar scaffolds [87, 88]. Supplementation of silk fibroins with 30% glycerol stabilized 
α-helix structures and more malleable films were obtained [89]. 
1.1.2.1.4 Synthetic polymers 
Unlike naturally derived polymers, scaffolds based on synthetic polymers are flexible in 
design and they don’t cause disease transmission. Synthetic polyesters composed of 
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lactide and glycolide monomers such as PLGA (poly [lactic-lactic-co-glycolic acid]) [90], 
and PLA (poly lactic acid) [91] constitute a commonly studied group of synthetic 
materials for cartilage tissue engineering. These materials have been used in medical 
applications for a long time [92, 93]. Degradation kinetics of these polymers can vary 
extensively in a scale of days to years depending on molecular weight, polymer 
morphology, crystallinity and composition [19, 94, 95]. Polymers of ε-caprolactone have 
good mechanical properties and slower degradability rate. Monomer ε-caprolactone can 
be copolymerized with glycolic acid and lactic acid. Insolubility of these polymers results 
in lower cell adhesion. Furthermore, acidic degradation products trigger an autocatalytic 
mechanism, which effects the fabricated scaffolds negatively [19, 96]. 
Another synthetic polymer is polyethyleneoxide (PEO), which can be obtained in the 
form of gel by cross-linking. Semi-interpenetrating network hydrogels supporting 
function and viability of chondrocytes were obtained by encapsulating chondrocytes in 
dimethacrylated PEG matrix and subsequently irradiating the PEO-PEODM mixture 
containing cells for photo-cross-linking [97].  
Among other synthetic polymer alternatives for cartilage regeneration are polyurethanes 
[98, 99], poly (N-isopropyl acrylamide) [100], poly vinyl alcohol [101] and carbon fibers 
[102].  
Naturally derived polymers offer biocompatibility and bioactive signals, while synthetic 
polymers offer flexibility in design and eliminated risk of contamination. Thus, efforts are 
directed towards hybrid materials combining the advantages of synthetic and natural 
materials. In this regard, more research is being carried on to develop various 
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combinations (involving synthetic polymers poly (α-hydroxy esters) and PEGs, 
manufactured with collagen [103], hyaluronic acid [104], chondroitin sulfate [105], 
alginate [106], fibrin [90]). 
1.1.2.1.5 Synthetic peptides 
Synthetic peptide technology enabled a wide range of opportunities in design and 
development of regenerative scaffold materials. Disadvantages of synthetic and natural 
polymers can be partially or completely eliminated with various peptides designed for 
functionalization or scaffold formation (Figure 2). Synthetic polymers can be made 
bioactive by modification with peptides [107-109]. 
Adhesive peptide sequences are important signals, which can be inserted on the 
backbones of inert synthetic polymers. Biological cell adhesion to extracellular matrix is 
the result of interaction between integrins, a family of cell surface receptors, and 
extracellular matrix elements like fibronectin, displaying the specific epitope (i.e. RGDS 
peptide). Integrins mediate between the extracellular matrix and cytoskeleton, and trigger 
the intracellular signaling pathways. Peptide nanofiber matrices exhibiting RGDS epitoe 
at van der Waals density were used for studying cell adhesion [110, 111].  
Construction of phage libraries allowed scientists to discover diverse functional peptide 
sequences. For example, WYRGRL is a peptide sequence revealed by phage display, 
which can specifically bind to collagens on cartilage tissue [112]. Microparticles 
functionalized with this peptide can deliver cargo selectively to cartilage tissue, increasing 
efficiency and mitigating side effects of the delivery system [112]. Another interesting 
feature of synthetic peptides is that they can form larger assemblies via physical 
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interactions if they are properly designed. Amphiphilic peptides with alternating 
hydrophilic and hydrophobic amino acids like poly (Val-Lys) [113], poly (Glu-Ala) [114], 
poly (Tyr-Lys) [115], poly (Lys-Phe) [116], poly (Lys-Leu), or [(Val-Glu-Val-Orn)1-3]-
Val [117] are inclined to assemble into β-sheet structures and form aggregates depending 
on pH or ionic strength of the medium. These β-sheet forming peptides with alternating 
polarity can form hydrogels, which are composed of micro-scale long fibers of 10-20 nm 
in diameter. These hydrogels resemble native cartilage with high water content and dense 
fibrillar structure and cells can be uniformly dispensed within their fibrillar network. 
When these hydrogels were used for three-dimensional culture of chondrocytes, they 
provided appropriate medium for chondrocytes to produce and deposit cartilage-like 
extracellular matrix for a period of as long as 4 weeks. Mechanical properties of the gels 
were enhanced, while cells accumulate new extracellular matrix [118]. Peptides, which 
show random coil to beta hairpin transition in response to various stimuli such as light, 
change in ionic concentration or pH, also form biocompatible hydrogels suitable for cell 
culture or cell delivery [119].  
A remarkable class of peptidic biomaterials in tissue engineering is composed of β-sheet 
forming small peptides conjugated to alkyl chains. Commonly known as peptide 
amphiphiles, these molecules primarily assemble via non-covalent interactions including 
hydrophobic interactions provided by alkyl chains and hydrogen bonds between amino 
acid residues to form nanofibrillar networks. Diverse design possibilities exist for these 
molecules including altering length of the alkyl tail, altering C-terminal amino acids 
which drive β-sheet formation and branched backbones. For example, modification of C-
terminal peptide part of peptide amphiphiles with bioactive molecules can provide these 
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molecules capability to support differentiation, maintenance, or proliferation of the cells 
[111, 120]. RGD presenting peptide amphiphiles have been used for a number of tissue 
engineering applications such as osteogenic differentiation of MSCs [120], or dental 
tissue regeneration [121]. Peptide amphiphiles with branched backbones were shown to 
be more effective for supporting cell adhesion and spreading [110, 111]. For culturing and 
implantation purposes, hydrogels of peptide amphiphiles had promising results for healing 
cartilage defects and degenerative joint diseases. A novel TGF-beta binding peptide 
revealed by phage display (i.e. HSNGLPL peptide) was integrated with peptide 
amphiphile structure to support regeneration of chondral defects and cartilaginous 
differentiation of mesenchymal stem cells. In vitro culture of mesenchymal stem cells in 
the presence of TGF-β, on hydrogels of peptide amphiphiles with TGF-β binding epitopes 
had remarkable results with increased expression of chondrocyte markers. The molecule 
was also applied with microfracture technique to defects on rabbit knees. When used with 
TGF-beta, peptide amphiphiles provided restoration of the functional tissue. Moreover, 
peptide amphiphiles were also capable of forming hyaline-like tissue formation in the 
absence of growth factor supplement [15, 122]. 
Peptides can be also designed by modeling functional domains of biologically active 
proteins. B2A is a synthetic peptide consisting of heparin binding fragment, hydrophobic 
fragment and BMP receptor binding fragment. With its receptor binding fragment (i.e. 
AISMLYLDENEKVVL), B2A binds to and modulates BMP2 receptors and promotes 
chondrogenic differentiation of mesenchymal stem cells [123].  
Synthetic peptides resembling natural collagens, called collagen mimetic peptides have 
been made subject of various inventions [124-126]. In their most basic form, collagen 
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mimetic peptides have the amino acid sequence –(Pro–Hyp–Gly)x– which is inspired 
from frequently repeated tripeptide in the amino acid sequence of collagen. Collagen 
mimetic peptides (CMPs) can form triple helices in aqueous environment, similar to 
native collagen proteins. Heat denaturation of triple helices formed by collagen mimetic 
peptides is reversible in contrast to collagen which turns into gelatin when heated. CMP 
has the ability to bind native or denaturated collagen I fibers. Three-dimensional culture 
of chondrocytes within PEG hydrogel modified with CMPs, improved synthesis of 
glycosaminoglycan and collagen compared to control PEG hydrogel. This result indicates 
improvement in cartilage tissue forming capacity of chondrocytes due to presence of 
CMPs, which possibly lead to greater interaction of cells with the extracellular matrix 
[126]. 
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Figure 2. Synthetic peptides in articular cartilage regeneration. Peptidic materials can be used for forming 
scaffolds and for numerous functionalization purposes. Properly designed peptides like peptide amphiphiles 
might act as building blocks for three dimensional networks on which cells can adhere and proliferate 
[110,117]. Peptide signals activating integrin mediated pathways such as RGD [110] and GFOGER [126] 
can be incorporated within scaffold for enhancing cell adhesion and spreading. Peptides may facilitate 
integration of scaffold with the tissue. Collagen mimetic peptides which are able to anneal with collagen 
chains of the native tissue constitute an example for specific peptides capable of enhancing integrity 
between scaffold and tissue [124-127]. Peptides affine to growth factors may be used for decorating scaffold 
fibers for binding and release of growth factors in a controlled manner [15,122]. Peptides than can 
specifically bind cartilage components can be used to functionalize microparticles for targeting cartilage 
tissue and minimize side effects associated with non-specific delivery of agents [112]. Peptides that are 
susceptible to specific extracellular enzymes may be inserted in the structure of the scaffold. In this way, 
degradation will be in response to cellular secretion of enzymes which may differ quantitatively during 
progress of differentiation [35]. Peptides targeting growth factor receptors can be developed for making 
synthetic growth factor analogs functioning to enhance chondrogenic differentiation [123]. 
 
1.1.2.1.6 Structural and mechanical properties of the scaffolds 
 Articular cartilage can withstand very high mechanical loads conducted by bones. 
Preferably, mechanical properties of scaffolds to be implanted should be similar with the 
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mechanical properties of native cartilage tissue. Materials should possess sufficient 
strength and stiffness for providing a temporary support which will act like functional 
cartilage tissue until complete tissue remodeling is achieved. In several studies, strength 
and stiffness of matrix was shown to be important in stimulation of various differentiation 
routes. Cells sense and react to scaffold mechanics by altering gene expression profile 
[127]. Mechanical properties of materials (i.e. compressive strength) are also important 
for their handling before and during implantation [128]. 
Articular cartilage owes its mechanical properties to the orientation of collagen and 
proteoglycan fibers and high density of negative charges provided by 
glycosaminoglycans, which draw high amounts of water. Composition and orientation of 
extracellular fibers vary throughout different zones of cartilage implementing specific 
mechanical properties at each zone (Figure 3A). An approach for mimicking specific 
structure of cartilage tissue is to construct hydrogels with multiple layers [129, 130]. In a 
recent study, three-layered hydrogel including cells was developed to achieve similar 
architecture to articular cartilage. All layers include polymerizable materials, while 
hyaluronic acid, chondroitin sulfate and MMP7 cleavable peptides with chondroitin 
sulfate were included respectively in different layers. Specific components of each layer 
were shown to stimulate cells to synthesize extracellular matrix proteins differentially 
enabling mimicking of natural layers within articular cartilage. According to the study, the 
layers were combined together by cross-linking gelling solution placed on top of the 
previously formed gel with UV irradiation. This was performed twice to obtain a three-
layered gel [130]. 
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Implants with oriented fibers aim to provide improved mechanical properties with better 
resemblance to architecture of native cartilage, which contains oriented collagen fibers. 
Electrospinning method has been also used to obtain scaffolds composed of randomly 
oriented fibers with very high mechanical strength and uniform distribution of fibers 
[131]. Electrospinning can also be used to obtain uniform scaffolds with fibers oriented in 
a parallel manner. Constructs with parallel aligned fibers, which could be used both for 
culturing cells and as implants for osteochondral defects were obtained by collecting 
electrospun fibers on winding shaft [132]. To make an implant with a similar architecture 
to fibrillar cartilage, triphasic implant construct with vertically aligned polymer hollow 
bodies were previously produced [133]. 
On several patents, hybridizing porous or fibrillar scaffolds with a secondary scaffold was 
performed for enhancing overall mechanical properties of the scaffold. Porous scaffold 
combined with a rapid prototyped backbone has advantages of uniformity, 
interconnectivity and mechanical stability [128]. Highly porous materials encapsulated 
within outer rims designed to distribute the compressive load were proposed as a possible 
solution for large articular defects [134]. Another example is three-dimensionally weaved 
structures filled with gelatinous material. This construct also enables high density seeding 
of cells with uniform distribution and high overall mechanical strength resembling the 
natural tissue [14]. Similarly, biphasic sponge-gel composites combine mechanical 
properties of sponge and cell seeding properties of gel to obtain a greater body [135].  
The scaffolds may be constructed in a variety of architectures such as sponges and 
fibrillar matrices. In all cases, porosity and interconnectivity of the scaffold are important 
parameters. Cells should be able to infiltrate between pores and migrate to form clusters. 
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Transport of nutrients and waste should be optimal. Freeze drying is a common process 
for obtaining porous matrices. An example is highly porous scaffolds obtained by 
lyophilizing chitosan-acetic acid solutions. The process mechanism depends on the 
separation of ice crystals from chitosan acetate salts during lyophilization. The pore sizes 
and pore orientations which are the main parameters influencing mechanical properties of 
the scaffolds can be controlled with rate of freezing and the geometry of thermal gradients 
[41, 77, 136]. Enlarging the pores in one side of the scaffold is also possible by leaching 
method [137]. 
 
Figure 3. Basic structure of articular cartilage and strategies for recapitulating architectural features, (A) 
Articular cartilage is composed of four distinct zones, superficial zone, middle zone, deep zone and calcified 
zone. Collagen fibers represented as black lines are arranged in a special way which is crucial for shock 
absorbing properties and resistance to high compressive loads. In superficial zone, collagen fibers are 
aligned parallel to each other; in the middle zone, fibers are partially aligned; in deep zone, fibers are mostly 
perpendicular to the plane of joint surface. Proteoglycans, represented by wavy lines, contribute to 
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mechanical properties by attracting water. Image was partially adapted from [132]. (B) Electrospinning 
method can be used for producing fibers aligned (a) randomly [131], or (b) in a parallel fashion [132]. 
Aligned fibers can be used to reinforce scaffolds like collagen fibers. (C) A scaffold with high mechanical 
strength can be combined with soft matrices for attachment and uniform distribution of cells. Solid free 
form techniques offer ways to design convenient architectures which can be shaped to exactly fit into the 
defect and to achieve mechanical properties similar to cartilage [128]. (D) Separate hydrogels may be used 
to mimic biochemical composition of different zones. Hydrogels with photosensitive chemical groups can 
be joined together through UV exposure. Image was partially adapted from [129, 130]. 
 
1.1.2.1.7 Injectable formulations 
One of the difficulties in the clinical application of engineered scaffolds for cartilage 
repair is requirement of surgical operation for inserting the scaffold into the defect area. 
Cross-linked materials in the form of hydrogel can be administered into the joint via 
injection, but high viscosity may cause difficulty during injection [138]. Thus, in situ 
forming hydrogels, which can be applied easily with injection, became a center of focus 
[139]. In general, hydrogels are composed of cross-linked polymer chains and 
supramolecular constructs that are able to absorb or encapsulate water to an excessive 
degree. The hydrogels may be formed in situ by injecting water soluble blends that are 
modified to show their gel forming behaviors under physiological conditions or by an 
external stimulus. In situ forming hydrogels can be formed by chemical or physical cross-
linking of components. Chemical cross-linking is established by joining functional groups 
on the backbone of polymer chains. Photo-cross-linking is a common example for 
chemical cross-linking. Physical cross-linking involves van der Waals interactions, 
hydrophobic interactions, hydrogen interactions and ionic interactions between the 
constituent atoms or groups of polymer chains [139]. Photo-cross-linkable materials were 
published in several patents as in situ gelling compositions, which can be applied within 
cartilage defects. A patented composition involves oligo (poly ethylene glycol) fumarate, 
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pyrrolidinone monomer and photo-initiator, which can be injected within cartilage defect 
and polymerized with UV exposure [11]. In another patent, a dual component system was 
defined in which similar components do not polymerize by themselves. Upon UV 
exposure interpenetrating or semi-interpenetrating networks are formed [140]. Collagen 
can also be combined with acrylated polyethylene glycol through artificially inserted thiol 
groups, which can be photo-polymerized by illuminating with UV to obtain hydrogels 
[141]. 
Hydrogels based on thermosensitive polymers, self assembling into micelles above a 
critical temperature and concentration can be utilized as injectable biomaterials for 
cartilage regeneration. Glycerol phosphate added chitosan solution is a well known 
thermo-gelling system, which shows transition to gel between 30-60 °C. Gelation occurs 
possibly through weakening of chitosan and water interactions due to glycerol phosphate 
mediated reorientation of water molecules and clustering of chitosan molecules into a 
larger assembly [78]. Chitosan and glycerol phosphate tend to gel or precipitate at room 
temperature when stored as a mixture. Holding these separately and mixing prior to 
implantation brought the advantage of longer term storage without formation of unstable 
structures [79]. Chitosan glucosamine salt compositions, which are injectable solutions 
with pH 6.5-7.6 at room temperature, can form gels when temperature exceeds a critical 
point which is about 25 °C[67].  
Various block polymers such as PEO-PLGA-PEO tend to gel in response to increase in 
temperature and these constitute alternative biocompatible in situ gelling systems [138]. 
Repair of cartilage defects with poly (DL-lactic acid-co-glycolic acid) / (poly (ethylene 
glycol) graft copolymer showing sol-gel transition above 37 °C has been reported [142]. 
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Hyaluronic acid can be attached to thermo-gelling block copolymers for prolonging the 
retention time of hyaluronic acid in the joint cavity. Modified hyaluronic acid product is 
also easily injectable and gels in the body [138]. 
Some of the patented injectable formulations include solutions, which can gel inside the 
body by interacting with abundant cations found within extracellular medium. Additional 
salts may be supplemented for better gelation. Alginate is a material which can gel by 
injection with divalent cations [86]. Acid solubilized collagen can be dialyzed against 
EDTA for removing trace amount of salts. Collagen solution obtained this way rapidly 
forms gel through fibrillogenesis when exposed to salts or fluids at 37 °C [46, 143].  
Peptide amphiphile molecules can also function as in situ forming injectable gels 
triggered by concentration, divalent cations or pH. Assemblies reaching from scales of 
microns to centimeters can be obtained [110, 111, 144]. Soluble peptidic materials can 
form three-dimensional matrices depending on the physical and chemical properties of 
their sequences. Amphiphilic peptides with alternating hydrophilicity can be delivered 
into the cavity with cells and bioactive agents. These peptides can form hydrogels that can 
encapsulate water in the range of 99-99.9% [118]. 
1.1.2.2 Cell sources for cartilage tissue engineering  
Chondrocytes from hyaline cartilage and nasal cartilage can be used as cell sources [145]. 
The cells are however unstable in monolayer (2D) culture; synthesis of proteoglycans and 
collagen II reduces while collagen I expression is upregulated. As a result, cells become 
fibroblast-like, losing phenotype as cartilage cells. Redifferentiation to original phenotype 
may be stimulated by culturing fibroblast-like cells in three dimensional environment. 
 
 
27 
 
Using serum free culture and FGF-2 supplementation lessen the effect of dedifferentiation 
and enables easier transition to chondrocyte phenotype [146]. Donor tissues may not be 
found frequently, another obstacle for utilization of chondrocytes as cell sources [145, 
147].  
Mesenchymal stromal cells isolated from adipose and bone marrow may also be utilized 
for cartilage tissue engineering [148]. MSCs are known as immunoregulatory cells as they 
are able to be ignored by immune recognition and block the host defense mechanisms 
[149].  
Another potential cell source for producing cartilage may be the chondrocyte precursors 
which can easily differentiate into chondrocytes when suitable conditions are supplied. 
Inner layer of periosteum consists of osteoblastic cells, responsible for local appositional 
bone growth. Osteoprogenitor cells produced in this layer mostly become osteoblasts but 
they also posses the chondrogenic potential [150].  
  
1.1.3 Cartilage and Chondrocyte Biology for Tissue engineering  
1.1.3.1 A general perspective for development of skeletal elements 
The origin of long skeletal elements for a tetrapod can be traced back to the formation of 
limb bud during embryogenesis. Cells from lateral plate mesoderm at specific locations in 
the flank become determined to form the limb primordium at specific limb fields. Exact 
mechanism for limb field positioning has not yet been elucidated. However, Hox genes 
such as Hoxc6, Hoxc8, and Hoxb5 are known to be major regulators for specification of 
forelimb and hindlimb locations [151]. After determination of the limb field positions, 
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specified cells within lateral plate mesoderm proliferate with a significantly higher cell 
division rate than non-determined cells [152]. As a result of differential proliferation, limb 
bud consisting of mesenchyme cells covered with an ectodermal jacket develops.  
At the most distal part of limb buds, ectodermal cells grow thicker to form a specialized 
structure called Apical Ectodermal Ridge (AER). Interaction of AER with mesodermal 
cells is particularly important for limb bud development. Its removal was reported to be 
resulting in cessation of limb bud growth [153, 154]. Adjacent to AER is the progress 
zone, where cells proliferate in the opposite direction to ectodermal ridge. Zone of 
polarizing activity, another important feature for limb bud development, is thought to act 
in symmetry [155]. 
To date, two different views exist for how joints between skeletal elements become 
specified. According to first view, formation of long bones starts with mesenchymal 
condensations which exist as uninterrupted bodies. The proximal part of a mesenchymal 
body gives rise to humerus or femur, distal part soon becomes radius/ulna or tibia/fibula 
and digits. During developmental progress, firstly, cells within mesenchymal bodies 
differentiate to chondrogenic cells as a response to secreted growth factors. For some cells 
at the putative joint region, ongoing chondrogenic differentiation is suppressed with 
antagonistic chemokines; choggin and nordin. These nonchondrocytic cells form the 
interzone separating the skeletal elements consisting of chondrocytic cells. In this way, 
three layers occur within the condensation, interzone and two outer layers. Joint 
ligaments, synovial lining originate from the cells of the interzone, the outer layers 
become the bones and the cartilage tissue covering the ends of bones [156]. 
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According to the other view, after mesenchymal condensation, skeletal elements which 
would later become bones, are initiated as independent chondrogenic entities and continue 
developing independently. Bones, humerus, radius and ulna, for example start as three 
discrete cartilaginous regions in a Y shaped mesenchymal condensation. Articular 
cartilage forms later as the cells from interzonal region differentiate to chondrocytes 
[157].  
Mesenchymal condensations, has been a subject of major interest, in order to enlighten 
skeletal development. Many mutations related to developmental abnormalities show their 
effect at the condensation stage [158]. 
1.1.3.2 Chondrogenic differentiation at monolayer cell culture  
At monolayer culture, chondrogenic differentiation is many times accompanied by 
aggregate formation similar to mesenchymal condensation at development. Monolayer 
culture studies with chondroprogenitor cells and mesenchymal cells have also been 
performed.  
ATDC5 is a feeder independent teratoma stem cell line. In the presence of insulin, 
ATDC5 cells migrate to form clusters which then become aggregates of approximately 
100 µm diameter. Chondrocyte markers like Collagen II, Aggrecan, Sox 9 are expressed 
at a higher level after cells form aggregates. Aggregation of ATDC5 cells resembles 
cellular condensation and subsequent chondrogenic differentiation during development 
[159, 160].  
Recently, directed chondrogenic differentiation of embryonic stem cells was succeeded 
with feeder independent two-dimensional (2D) cultures. Interestingly, stages of 
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chondrogenic differentiation of embryonic stem cells are very similar to the stages 
observed for ATDC5 cells [161].  
Primary chondrocytes, also form aggregates when seeded on indented surfaces with 
micro-scale grooves. These chondrocytes maintained type II collagen expression and 
round morphology. On the other hand, when cultured on flat tissue culture plate, 
chondrocytes gained fibroblast like morphology, indicating dedifferentiation of cells 
[162].  
Chondrogenic condensation process has many complications and unknowns to be 
revealed. A late study was into skeletal morphogenesis and put forward a hypothetical 
scheme for condensation and cartilage formation. According to this scheme condensation 
starts by cell sorting where proximally or distally determined cells are accumulated within 
distinct aggregates which are partly homogenous in cell determination which then forms 
proximo-distally specified clusters. Clusters then compact into tighter, less spread cellular 
bodies. In compaction step, BMP signaling is considered to be the main driver. Activation 
of the transcription factor Sox9 provides cells to gain and maintain chondrogenic 
phenotypes [163]. 
Figure 4. Postulated condensation steps during cartilage formation [163] 
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1.2 Experimental Section 
1.2.1 Materials 
Fmoc protected aminoacids (NovaBiochem, Sigma Aldrich), Rink amide MBHA resin 
(NovaBiochem), Lauric acid (Merck), 2-(1H-Benzotriazole-1-yl)-1,1,3,3-
tetramethyluronium tetrafluoroborate (HBTU) (ABCR), triisopropylsilane (AlfaAesar), 4-
sulfobenzoic acid, 95% (AlfaAesar), were some of the chemicals used for synthesis of 
peptide amphiphiles. Fmoc-Glu(OtBu)-Wang resin was synthesized by Ruslan Garifullin. 
Other chemicals and solvents like dichloromethane, N,N-dimethylformamide, N-
ethyldiisopropylamine, trifluoroacetic acid, diethylether, acetonitrile, and ammonium 
hydroxide were purchased from Sigma-Aldrich, Alfa Aesar and Merck.  
1.2.2 Design, synthesis and purification of functional peptide 
amphiphiles for chondrogenic differentiation 
Peptide amphiphiles constitute a class of molecules containing soluble peptide groups 
linked to hydrophobic alkyl tail. The role of alkyl tail is to drive molecular assembly 
through hydrophobic interactions. Peptide sequence mostly determines the type and 
geometry of self assembly. Design of the molecules used in this study has been used in a 
variety of studies [164-166].  
Three peptide amphiphiles were synthesized in this study, GAG-PA, Glu-PA, Lys-PA. On 
the N-terminal, each PA molecule has a hydrophobic tail constituted of 12 carbons. 
Length of 12 C provides the sufficient hydrophobicity for micelle formation yet 
dynamicity of the network formation is preserved. The first four amino acids attached to 
 
 
32 
 
C12 tail, with the sequence “VVAG” interact with each other via intermolecular hydrogen 
bonds which collectively form beta sheets in aqueous solution. A charged spacer amino 
acid and the bioactive sequence follow the beta sheet forming sequence.  
In this study, GAG-PA (Figure 5c) was designed to present a glycosaminoglycan mimetic 
sequence at its C-terminal. Lys-PA (Figure 5b) and Glu-PA (Figure 5a) do not carry any 
specific bioactive signal. Lys-PA is positively charged at neutral pH with the sequence, 
C12-VVAGK-Am. Glu-PA is negatively charged at neutral pH with the sequence C12-
VVAGE-OH. Lys-PA and Glu-PA were used for adjusting the net charge of the scaffolds, 
and for constituting scaffolds without bioactive signals.  
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Figure 5. Chemical structures of peptide amphiphiles (a) Glu-PA, (b) Lys-PA, (c) GAG-PA 
(a) 
(b) 
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Figure 6. Schematics of Fmoc Solid Phase Peptide Synthesis  
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1.2.2.1 Synthesis of peptide amphiphiles  
Peptide amphiphiles used in this study were synthesized with standard solid phase Fmoc 
chemistry. Synthesis protocol is represented at Figure 6. Rink Amide MBHA resin (for 
GAG-PA and Lys-PA), Fmoc-Glu-(OtBu)-Wang (for Glu-PA) were used as solid 
supports. Starting amounts of resins which were determinative for the theoretical yield 
were either 0.25 mmol or 0.50 mmol. Fmoc groups were cleaved by treating the solid 
phase with 20% piperidine in DMF for a period of 20 minutes. Fmoc protected amino 
acids were dissolved in 10 ml DMF and activated with O-Benzotriazole-N,N,N’,N’-
tetramethyl-uronium-hexafluoro-phosphate (HBTU), and N-ethyl-diisopropylamine 
(DIEA) in an equivalency ratio of 2:1.95:3, respectively showing the relative amounts of 
Fmoc protected amino acid, HBTU and DIEA with respect to the theoretical yield. 
Coupling of Fmoc protected amino acid and growing peptide chains was carried out for 2 
hours in the reaction vessel. Kaiser test was performed at the end of each coupling, for a 
rough evaluation of reaction’s completeness. Coupling was repeated if it was incomplete 
according to the test. For the purpose of blocking unreacted ends, resin was treated with 
10% acetic anhydride for 30 minutes after each coupling. After coupling all Fmoc 
protected amino acids by applying the steps mentioned above, alkyl tail was attached 
following the same protocol, but using lauric acid instead of Fmoc protected amino acid. 
Fully grown peptide amphiphiles were cleaved from resin, and side chain protective 
groups of functional groups were removed in a cleavage step of 2 hours with 
trifluoroacetic acid (TFA): triisopropylsilane (TIS): water at the ratio of 95:2.5:2.5. 
Solution containing the cleavage products was collected at a round bottom flask and resin 
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was washed several times with DCM. DCM was removed, and TFA was removed to a 
large extent with rotary-evaporation. Peptide amphiphile was triturated by adding ice-cold 
diethylether into the solution which was left overnight at -20 ˚C. Diethylether was 
decanted after centrifugation at 8000 rpm for 15 minutes. Product was dissolved in 
ddH2O, frozen at -80 ˚C and freeze-dried at -50 ˚C for two days.  
1.2.2.2 Purification of peptide amphiphiles  
Peptide amphiphiles were purified with reverse phase HPLC system equipped with 
Zorbax Extend-C18 21.2 x 150 mm column for Glu-PA and GAG-PA. Before performing 
HPLC, the column was cleaned with a gradient up to 100% of solvent B to eliminate any 
peptidic material that remained absorbed on the column. Pure peptide amphiphile was 
eluted applying a linear gradient of 2% to 70% of solvent B for a period of 30 minutes. 
(A: 0.1% ammonium hydroxide in water B: 0.1% ammonium hydroxide in acetonitrile.) 
Since impurities within Lys-PA were minimal, Lys-PA was not purified.  
1.2.3 Chemical and physical characterization of peptide amphiphiles 
and peptide amphiphile combinations  
1.2.3.1 LC-MS 
Molecular mass and purity of peptide amphiphiles were confirmed with Agilent 6530-
1200 Q-TOF LC-MS equipped with ESI-MS.. Purity by peptide content was monitored at 
220 nm. For Lys-PA Zorbax Extend-C18 21.2 x 150 mm column, and for GAG-PA and 
Glu-PA Zorbax Extend C18 column were used. A: 0.1% trifluoroacetic acid in water and 
B: 0.1% trifluoroacetic acid in acetonitrile gradient was used.  
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1.2.3.2 Oscillatory rheology  
Oscillatory rheology measurements were performed with Anton Paar Physica MCR301. 
For all measurements 25 mm parallel plate was used at 0.5 mm interval. Total gel volume 
was adjusted to fill the whole cylindrical space between the stage and the plate. PA 
solutions of 10 mM were freshly prepared, sonicated for 30 minutes. After loading one 
PA solution at the center of the stage, counter charged PA solution was added dropwise 
on it. Just after, plate was brought to measurement position. For maturation gel was 
incubated in this position for 15 minutes before initiating the measurement. For strain 
sweep measurements, angular frequency was kept constant at 10 rad/s, strain was 
increased between 0.1%-100%, storage and loss moduli were recorded at each strain. 
1.2.3.3 Circular Dichroism 
Circular Dichroism study was performed with J-815 Jasco spectrophotometer. All spectra 
were obtained at a wavelength interval of 190-300 nm. Spectra were obtained at a digital 
integration time of 4 s, bandwidth of 1 nm, and data pitch of 0.1 nm. Three subsequent 
spectra were averaged for each sample. Quartz cuvettes with 2 mm pathlengths were used 
for measurements. According to the following formula, ellipticity was converted to molar 
ellipticity with the unit degree cm2 mol-1.  
 
 [θ]: Molar ellipticity, θ: Ellipticity in degrees, C: Concentration in M, l: length in cm 
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1.2.4 Monolayer (2D) culture of ATDC5 cells on peptide amphiphile 
scaffolds  
1.2.4.1 Peptide amphiphile coating on polystyrene multiwell plates 
Pure peptide amphiphiles, GAG-PA, Lys-PA and Glu-PA were dissolved in ddH2O. pH of 
peptide amphiphile solutions were approximately adjusted to 7. PA solutions were 
sonicated for 30 minutes. Concentration of PAs was measured with Nanodrop. Four 
different combinations were determined for coating surface of tissue culture plate wells. 
Peptide amphiphiles were combined, each PA at 1 mM concentration at the ratio given in 
Table 1.  
For two of the combinations, PA content were adjusted in a way to satisfy full 
neutralization, while excess one negative charge in total was considered for the other two 
combinations. In order to provide homogenous coating, PAs of same charge were firstly 
added to wells, and then counter-charged PAs together were added dropwise to nearly all 
areas of the wells slowly. Coatings were left for about two days in laminar flow hood for 
drying. After drying, coatings were UV sterilized.   
Table 1. Formulations used in the study for obtaining scaffolds 
Combinations PA content % (PA volume/total volume x 100) 
Scaffold, Net charge GAG-PA Glu-PA Lys-PA 
GAG-PA/ Lys-PA, neutral 25 - 75 
Lys-PA/ Glu-PA, neutral - 33.3 66.6 
GAG-PA+Glu-PA/ Lys-PA, negatively 
charged 25 33.3 41.7 
Lys-PA/ Glu-PA, negatively charged - 50 50 
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1.2.4.2 Monolayer culture conditions 
ATDC5 cells were cultured on PA coated 96-multiwell plates, 48-multiwell plates and 24-
multiwell plates according to the aim of the experiment. As control, cells were also seeded 
on non-coated polystyrene wells. For 96-multiwell plates 10000 cells/well, for 48-
multiwell plates 20000 cells/well, and for 24-multiwell plates 50000 cells/well were 
determined as initial cell seeding density. Cells were cultured with either maintenance 
medium containing 1:1 mixture of Dulbecco’s modified Eagle’s medium (DMEM) and 
Ham’s F12 supplied with 10 µg/ml human transferring (Sigma-Aldrich), and 5% FBS or 
with differentiation medium containing maintenance medium plus 10 µg/ml bovine 
insulin. Cell culture studies were carried out by Seher Üstün. 
1.2.4.3 MTT assay 
ATDC5 cells were cultured on 96-multiwell plates at a density of 15000 cells per well 
using maintenance medium without phenol red. At specific time points grown cells were 
treated with MTT reagent and absorbance values were recorded with plate reader. Data 
obtained for each scaffold combination (n=3) were normalized with respect to cells grown 
on tissue culture plate to obtain relative cell quantity.   
1.2.4.4 Quantitative analysis of aggregates 
Cell aggregates were grown on scaffolds for 18 days (three wells for each scaffold 
combination). During follow-up, 10 non-overlapping 5x photo frames were taken from 
each of three wells periodically. Size values of aggregates (area, perimeter, major, minor) 
and number of aggregates were quantified with ImageJ for each frame. For each well, 10 
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frames were pooled to determine the number of aggregates per well and the average area 
of aggregates. Average area was calculated according to: 
  
Mean values and standard deviations were obtained from 3 wells.  
1.2.4.5 Safranin-O staining 
Cells were fixed with 4% PFA in PBS for 15 minutes. Fixed cells were washed with PBS 
then treated with 2% BSA for 30 minutes for blocking to prevent nonspecific staining of 
the scaffold. Fixed cells were stained with 0.1% Safranin-O in 0.1% acetic acid for 5 
minutes at room temperature, and then washed with PBS. 
1.2.4.6 Scanning electron microscopy 
Cell aggregates grown for 5 days on Glu-PA/Lys-PA coated slides were washed three 
times with PBS and fixed with gluteraldehyde for 1.5 hours, then treated with Osmium 
tetroxide for 30 minutes. The samples were dehydrated with a series of ethanol of 
increasing concentrations. Samples were, critical point dried and Au-Pd coated. Sample 
preparation was done by Seher Üstün. Critical point drying and SEM was performed in 
cooperation with Yavuz Selim Dağdaş. 
1.2.4.7 Immunocytochemistry 
Collagen II production of aggregates were evaluated with immunocytochemistry with 
collagen-II antibody. Cell aggregates grown for 14 days on GAG-PA+Glu-PA/Lys-PA 
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scaffold were washed three times with PBS and fixed with 4% PFA in PBS for 15 minutes 
and then blocked with 10% BSA treatment for 30 minutes. For immunofluorescence 
staining incubation with primary antibody was carried overnight. Next day, after washing 
three times with with PBS, aggregates were incubated with secondary antibody for one 
hour.  
For nuclei staining, samples were treated for PBS-TX 0.1% for 10 minutes and then 
incubated with nuclei staining dye TO-PRO. 
All staining protocols were carried in dark. The stainings were performed together with 
Seher Üstün. 
1.3 Results and Discussion 
1.3.1 Characterization of peptide amphiphiles and peptide amphiphile 
scaffolds 
Three peptide amphiphiles were synthesized in order to construct scaffolds for culture of 
ATDC5 cells. Crude products were purified if the amount of impurities exceeded 80% by 
peptide content. GAG-PA, Glu-PA and Lys-PA had expected molecular weights (Figure 
7, 9, 10); with high purities (Figure 8, 10, 12). 
GAG-PA contains sulfobenzoyl, carboxyl and hydroxide groups in its structure 
mimicking glycosaminoglycans. Main rationale in the design of this peptide amphiphile 
was that the composition of cartilage tissue mainly involves proteoglycans with 
negatively charged glycosaminoglycans and scaffolds carrying GAG signals would help 
chondrogenic differentiation.  
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Counter charged peptide amphiphiles of 1% (w/v) concentration together formed self-
supporting gels which could be seen with naked eye. This is an expected result indicating 
the formation of nanofiber networks.  
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Figure 7. Electrospray ionization mass spectra of the Glu-PA. [M-H+]-1observed=654.42, [M-H+]-1calculated=654.82, [M–2H+]-2/2 observed =326.7, [M–2H+]-2/2 calculated = 
326.91 
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Figure 8. Reverse Phase-HPLC chromatogram of Glu-PA. Retention time 12-13 minutes  
 
 
 
 
 
45
 
 
 
Figure 9. Electrospray ionization mass spectra of the Lys-PA. [M+H+]+1observed=654.51, [M+H+]+1calculated=654.9, [2M+H+]+1observed =1307.9, [2M+H+]+2calculated = 
1308.8  
 
 
 
 
 
46
 
    
 
Figure 10. Reverse phase-HPLC chromatogram of Lys-PA. Retention time 15-16 minutes 
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Figure 11. Electrospray ionization mass spectra of the GAG-PA. [M-H+]-1observed= 1224.59, [M-H+]-1calculated= 1224.59, [M–2H+]-2/2 observed = 611.792, [M-2H+]-2/2 
calculated = 611.795 
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Figure 12. Reverse phase-HPLC chromatogram of GAG-PA. Retention time 10-11 minutes 
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Formation of nanofibers from peptide amphiphiles is driven by hydrophobic interactions and beta 
sheet forming ability of the peptide sequence, Val-Val-Ala-Gly-. Since, formation of beta-sheets 
was essential for self assembly, and for scaffold formation, secondary structure of individual 
peptide amphiphiles and four different combinations were investigated with Circular Dichroism 
(Figure 13).  
Circular Dichroism spectra of polypeptides are based on the interaction of chromophores that are 
arranged in a specific way within a chiral environment. Secondary structure of polypeptides is 
associated with the patterns observed within spectra.  
At neutral pH, Glu-PA and GAG-PA exhibit the characteristic random coil spectra with the 
minima around 198 nm. Lys-PA has a spectrum similar to the negatively charged peptide 
amphiphiles, however with a broader signal around 200 nm and a minimum around 220. This is 
most possibly a compound spectra involving both random coil and beta sheet signals. Lys-PA 
may be forming some primary forms of self-assembly. Theoretically, GAG-PA and Glu-PA carry 
3 and 2 negative charges respectively at pH 7, whereas Lys-PA has one positive charge. 
Electrostatic repulsion of the identical charges, counteracts the hydrophobic interactions and 
hydrogen bonds which work together to initiate self assembly. Two net charges may be capable 
to drive individual molecules apart and one net charge might have been insufficient to completely 
block the assembly in the case of Lys-PA.  
Peptide amphiphiles were combined in ways to have full neutralization or one net negative 
charge. When Lys-PA was added to neutralize negative charges of Glu-PA and GAG-PA, 
random coil bands immediately disappeared and beta-sheet was observed instead with maxima at 
around 200 nm and minima at around 220 nm.  
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Glu-PA and Lys-PA were mixed in one to one ratio or one to two ratio, theoretically resulting in 
negatively charged or neutralized systems. However, these two different ways of mixing resulted 
in nearly the same spectra. 
GAG-PA and Lys-PA were mixed in one to three ratio to have a neutralized system. In this case 
the spectrum was similar with the spectra of Glu-PA/Lys-PA systems, but with different θ200:θ 220 
ellipticity proportion. Without changing the molar percentage of GAG-PA to the total peptide 
content, Glu-PA was inserted to the system to obtain net one negative charge. θ200:θ 220 proportion 
changed to resemble more to the Glu/Lys spectrum. There isn’t vast information in literature on 
whether such differences in the Circular Dichroism spectra are reflections to minor changes in 
secondary structure. However, a proportion θ200:θ220 with enhanced θ200 and a minute red shift in 
π-π* transition region in the case of Glu-PA/Lys-PA, may be an indication of twisted beta sheet 
structure [167]. 
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Figure 13. Circular Dichroism spectra for various PA combinations         
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Gel formation properties of the same combinations used in Circular Dichroism were investigated 
with oscillatory rheology.  
Storage and loss moduli were measured at varying strains and constant angular frequency. 
Storage modulus corresponds to the energy stored within the material and resist when forces act 
to deform the gel. Loss modulus corresponds to energy that is dissipated when the material is 
deformed. Material is considered as gel when storage modulus exceed loss modulus [168] .  
Strain sweep tests show that counter-charged PA molecules form gels which stay in linear 
viscoelastic region up to 1% strain. Beyond 1% strain, gels gradually lose mechanical strength, 
and stability. At 0.5% strain, storage moduli of gels changed between 1-3kPa, loss moduli 
between 200-500 Pa. At this particular strain, neutralized GAG-PA/Lys-PA gel is significantly 
stronger. Other three combinations are closer in stiffness, without displaying any significant 
difference in storage and loss moduli. It is noteworthy that neutralized GAG-PA/Lys-PA has a 
different Circular Dichroic profile.  
Both interfiber and intrafiber bonds contribute to macro-mechanical properties of the fibrillar 
network system. Ten fold larger storage moduli of Ca2+ gels with respect to storage moduli of 
HCl gels was apparently attributable to interfiber bonds rather than intrafiber bonds [164].  
In this work, extra negative charge present in two combinations may have lead to reduction in gel 
stiffness due to interfibrillar repulsions. On the other hand, there may be slight changes in the 
secondary structure of combinations, depending on the presence of GAG-PA or Glu-PA. Besides 
interfiber interactions, intrafiber bonds may have played an important role in overall mechanical 
strength.
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Figure 14. Strain sweep oscillatory rheology measurements of gels with GAG-PA, (a) GAG-PA + Glu-PA/Lys-PA 
(- charge), (b) GAG-PA/Lys-PA (neutral)  
(a) 
(b) 
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Figure 15. Strain sweep oscillatory rheology measurements of gels without GAG-PA, (a) Glu-PA/Lys-PA (- charge), 
(b) Glu-PA/Lys-PA (neutral) 
 
(a) 
(b) 
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Figure 16. Strain and loss moduli of gels at 0.5% strain and 10 rad/s, values represent mean ±SD, n=2 
 
 
 
56 
 
Formation of gels when mixed with oppositely charged molecules is desired for a 
biomaterial to be used in cartilage regeneration, since such material can be applied with 
easy injection procedure and does not require complex operations. Peptide amphiphiles 
used in this study are soluble around physiological pH due to charged amino acids in their 
structure. When, these charges are neutralized, weak interactions become prominent and 
three-dimensional network is rapidly assembled. From this perspective, when rheological 
properties of synthesized PAs are taken into consideration, these PAs hold promise as 
injectable biological scaffolds.  
1.3.2 Monolayer culture of ATDC5 cells on scaffolds 
ATDC5, a chondroprogenitor cell line was used to constitute a model for chondrogenesis 
on coated PA layers. Differentiation of ATDC5 towards chondrocyte like phenotypes has 
been subject of many studies. In the presence of insulin or insulin-like growth factor 
(IGF), ATDC5 cells form aggregates and while expression of Col-II, and Sox9 increases.  
ATDC5 cells were seeded on polystyrene plates with or without peptide amphiphile 
coating. Interestingly, ATDC5 cells formed aggregates when seeded on PA coated wells, 
even though insulin was not present in the medium. Aggregation process was followed for 
a 21 day period and evaluated for different aspects.  
1.3.2.1 MTT assay  
MTT assay was done in order to assess viability of the scaffolds. However within 48 
hours, ATDC5 cells aggregated unexpectedly, even though insulin which is considered as 
the required factor for differentiation of ATDC5 cells was not present within the medium. 
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On the other hand, no morphological change was observed for ATDC5 cells seeded on 
uncoated tissue culture plate wells.  
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Figure 17. MTT assay cell quantities normalized with respect to cells grown on tissue culture plate (a) 48h (b) 72 h 
(c) 96 h (d-g) ATDC5 cells on coated wells (d) Glu-PA/Lys-PA (- charge) (e) GAG-PA + Glu-PA/Lys-PA (- charge) 
(f) Glu-PA/Lys-PA (neutral) (g) GAG-PA + Glu-PA/Lys-PA (neutral) (h) ATDC5 cells on uncoated well 
(h) 
(b) 
(c) (d) 
(e) 
(f) 
(g) 
(a) 
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Aggregation of ATDC5 cells is a process that is observed during chondrogenic 
differentiation. Aggregation in the absence of any bioactive signals might be explained 
with possible absorbtion and stabilization of autocrine factors released by ATDC5 cells on 
nanofibers. Bioactive factors with increased density possibly stimulated cells for 
differentiation.  
Since growth of cells might be ceased by chondrogenic differentiation, MTT results 
obtained and normalized with respect to uncoated plate, do not truly reflect viability 
profiles of cells grown on PA scaffolds. This can also be validated from 10x LM images; 
cells forming larger aggregates generally had lower cell quantity.  
1.3.2.2 Formation of ATDC5 aggregates  
1.3.2.3 Morphology of aggregates and ATDC5 cells on different 
scaffolds 
After observing aggregate formation of ATDC5 cells on scaffolds without supplementing 
any bioactive signals after 48 hours, ATDC5 cells were seeded on each PA combination 
and observed for a 20 day period.  
Aggregation starts 1 day after seeding ATDC5 cells on scaffolds. On day 3, cell clusters 
seem to be dispersed with more spread cells. The clusters on day 3, do not have distinctive 
borders and strict circular shape. Through day 7, cell clusters become compacter, round 
aggregates with more distinctive borders. From 7 days to 18 days, aggregates increase in 
size, reaching an assumptive diameter of 100-300 µm on day 18. Cellular bridges between 
aggregates were notable features. Another interesting point was that, aggregates unified to 
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form larger aggregates with the shape of intersecting Venn diagrams or unified spheres. 
On day 18, aggregates became so compact that individual cells within aggregates could 
hardly be identified. This might also be due to the growth of cells at the third dimension, 
production and coverage of dense extracellular matrix. Even hydroxiapatite crystals might 
have formed on aggregates.  
Progress of ATDC5 aggregation on peptide amphiphile scaffolds, fits to an aggregation 
scheme proposed for cartilage formation [163]. According to this scheme cells starts to 
form dispersed clusters which get larger. A next step is the compaction of the clusters. In 
this step, associations between cells get stricter. Compaction of clusters is told to be 
mediated by BMP signaling. Compact aggregates increase in size. Sox 9 expression 
induces cells to chondrocyte like phenotypes.  
In a separate study, primary chondrocytes were seeded on surfaces with stripes of nano-
size on which chondrocytes formed aggregates. Time-lapse imaging of cells revealed, 
collision of cells to form aggregates and collision of smaller aggregates to form larger 
aggregates [162]. This mechanism might also be valid for our study, since unification of 
aggregates was observed.  
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Figure 18. ATDC5 cells grown on GAG-PA/Lys-PA (- charge) (a) 1 day (b) 3 days (c) 7 days , (d) 17days (e), (f) 18 
days 
(a) (b) 
(c) (d) 
(e) (f) 
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  Figure 19. ATDC5 cells grown on Glu-PA/Lys-PA (a)1 day (b) 3 days (c) 7 days (d) 17 days (e), (f) 18 days
(a) (b) 
(c) (d) 
(e) (f) 
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1.3.2.4 Quantitative analysis of aggregates on different peptide 
amphiphile scaffolds 
Average areas of aggregates, total aggregate area and number of aggregates on different 
scaffolds were followed through 18 days. Effect of insulin was also investigated; two 
replicates of the experimental set up included media with insulin or media without insulin.  
On three scaffolds, Glu-PA/Lys-PA (neutral), Glu-PA/Lys-PA (- charge), GAG-PA+Glu-
PA/Lys-PA (- charge), average area of aggregates followed a similar trend during the 18 
day-period. On these scaffolds, average area of aggregates increased slightly, through 5 to 
11 days. Between days 11-14 and 14-18, average area increased more significantly. On 
both Glu-PA/Lys-PA scaffolds, the increase was very steep as opposed to GAG-PA+Glu-
PA/Lys-PA (- charge). A sudden decrease in number of aggregates and significant 
increase in total area of aggregates, accompanied the sharp transition observed during 11-
18 days. Unified aggregates started to appear from day 11, and unification increased 
through day 18 and as a result number of aggregates decreased and the average area 
increased. Increase in total area during this period (11-18 days) might be a result of 
coalescing of individual cells or very small clusters with aggregates.  
For GAG-PA+Glu-PA/Lys-PA (- charge) scaffold, average aggregate areas on different 
days were smaller than other scaffolds. However, number of aggregates was much more 
than the others. Number of aggregates decreased below 100 at 18th day in the absence of 
insulin, below 50 at 18th day in the presence of insulin for scaffolds other than GAG-
PA+Glu-PA/Lys-PA (- charge). For GAG-PA+Glu-PA/Lys-PA (- charge), number of 
aggregates remained 250-350 in the absence of insulin, about 100-150 in the presence of 
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insulin. From 9th day to 18th day the total area of aggregates in the absence of insulin was 
significantly larger for GAG-PA+Glu-PA/Lys-PA (- charge) scaffold when compared to 
total area for other scaffolds. In the presence of insulin, total area for this scaffold was 
larger than total area of other scaffolds through all days. 
On 5th day, on GAG-PA/Lys-PA (neutral), aggregates were already had 2 times larger 
than the aggregates on other scaffolds. This shows that aggregation starts earlier on GAG-
PA/Lys-PA (neutral) scaffold. The average area of aggregates on this scaffold, increased 
very slightly till 18th day. GAG-PA/Lys-PA (neutral) and GAG-PA+Glu-PA/Lys-PA (- 
charge) scaffolds had the same ratio of GAG-PA to total peptide amphiphiles. Different 
behavior of cells on GAG-PA/Lys-PA (neutral) scaffold might be relevant to differences 
in secondary structure and mechanical properties which were noted in Circular Dichroism 
and Rheology experiments.  
When insulin was present in the media, progress of aggregation followed almost the same 
trend of increase in average area and decrease in number which was observed for cells 
cultured without insulin. Presence of insulin in the media, however, provided a rough 
doubling of the average aggregate areas and rough halving of the aggregate numbers for 
every combination. This is sound, since same numbers of cells were seeded initially. 
When total area of aggregates is considered, any profound effect triggered by insulin 
cannot be seen in general. Particularly, GAG-PA+Glu-PA/Lys-PA (- charge) as well as 
Glu-PA/Lys-PA (- charge) scaffolds initially had larger total area. 
All together, these data may be suggesting that insulin did not pursue a proliferative role; 
it rather acted in aggregate formation and cell migration.  
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Figure 20. Average aggregate areas for ATDC5 cells grown on GAG-PA/Lys-PA (neutral), GAG-PA/Lys-PA (- 
charge), Lys-PA/Glu-PA (neutral) and Lys-PA/Glu-PA (- charge) for 18 days in media without insulin (at top), or 
with insulin (at bottom). Values represent mean ± S.D. (n=3) 
 
5 7 9 11 13 15 17 19
0
100
200
300
400
500
600
700
800
900
1000
1100
1200
1300  Glu PA/Lys PA (neutral)
 GAG PA/Lys PA (neutral)
 Glu PA/Lys PA (- charge)
 GAG PA+Glu PA/Lys PA (- charge)
A
ve
ra
ge
 a
gg
re
ga
te
 a
re
a 
(x
 1
00
00
0 
pi
xe
l2 )
Days
5 7 9 11 13 15 17 19
0
200
400
600
800
1000
1200
1400
1600
 Glu PA/Lys PA (neutral)
 GAG PA/Lys PA (neutral)
 Glu PA/Lys PA (- charge)
 GAG PA+Glu PA/Lys PA (- charge)
A
ve
ra
ge
 a
gg
re
ga
te
 a
re
a 
(x
10
00
00
 p
ix
el
2 )
Days
 
 
66 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
Figure 21. Total areas for ATDC5 cells grown on GAG-PA/Lys-PA (neutral), GAG-PA/Lys-PA (- charge), Lys-
PA/Glu-PA (neutral) and Lys-PA/Glu-PA (- charge) for 18 days in media without insulin (at top), or with insulin (at 
bottom). Values represent mean ± S.D. (n=3) 
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Figure 22. Number of aggregates for ATDC5 cells grown on GAG-PA/Lys-PA (neutral), GAG-PA/Lys-PA (- 
charge), Lys-PA/Glu-PA (neutral) and Lys-PA/Glu-PA (- charge) for 18 days in media without insulin (at top), or 
with insulin (at bottom). Values represent mean ± S.D. (n=3) 
5 7 9 11 13 15 17
0
50
100
150
200
250
300
350
400
450
 Glu PA/Lys PA (neutral)
 GAG PA/Lys PA (neutral)
 Glu PA/Lys PA (- charge)
 GAG PA+Glu Pa/Lys PA (- charge)
N
um
be
r o
f a
gg
re
ga
te
s 
Days
5 7 9 11 13 15 17 19
0
20
40
60
80
100
120
140
160
180
200
220
240
260
280
 Glu PA/Lys PA (neutral)
 GAG PA/Lys PA (neutral)
 Glu PA/Lys PA (- charge)
 GAG PA+Glu PA/Lys PA (- charge)
N
um
be
r o
f a
gg
re
ga
te
s
Days
 
 
68 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 23. Average perimeters for ATDC5 cells grown on GAG-PA/Lys-PA (neutral), GAG-PA/Lys-PA (- charge), 
Lys-PA/Glu-PA (neutral) and Lys-PA/Glu-PA (- charge) for 18 days in media without insulin (at top), or with 
insulin (at bottom). Values represent mean ± S.D. (n=3) 
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1.3.2.5 Safranin-O Staining  
Safranin-O is a cationic dye which binds to proteoglycans in cartilage in its 
orthochromatic form. Thus, it has been widely used for detecting changes in articular 
cartilage. Sarfanin-O is also used for detecting chondrogenesis as production of 
proteoglycans is accepted as a measure of chondrogenic differentiation.  
Aggregates at various stages were stained with Safranin-O. ATDC5 cells that were grown 
on tissue culture plate, formed a confluent layer without any aggregates. These cells were 
faintly stained with Safranin-O (Figure 20-21 g, h). On the other hand, primary rabbit 
chondrocytes which are native of cartilage tissue had more lively stain (Figure 20-21 f).  
On days 5, 9 and 14, aggregates formed on GAG-PA + Glu-PA/Lys-PA (- charge) and 
Glu-PA/Lys-PA (- charge) stained heavily with Safranin-O.  
 
 
 
70 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
  
 
 
Figure 24. Safranin-O staining of ATDC5 cells and primary rabbit chondrocytes.
Aggregates of ATDC5 cells seeded on Glu PA/Lys PA (- charge ) (a,b) for 5 days,
(c,d) for 9 days, (e) for 14 days, (f) primary rabbit chondrocytes seeded on polystyrene
culture plate, (g,h) ATDC5 cells seeded on polystyrene culture plate
(a) (b) 
(c) (d) 
(e) (f) 
(g) (h) 
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Figure 25. Safranin-O staining of ATDC5 cells and primary rabbit chondrocytes.
Aggregates of ATDC5 cells seeded on GAG-PA+ Glu PA/Lys PA (- charge ) (a,b) for 5
days, (c,d) for 9 days, (e) for 14 days, (f) primary rabbitt chondrocytes seeded on
polystyrene culture plate, (g,h) ATDC5 cells seeded on polystyrene culture plate 
(a) (b) 
(c) (d) 
(e) (f) 
(g) (h) 
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1.3.2.6 Scanning Electron Microscopy 
Microphotographs of aggregates grown on Glu-PA/Lys-PA (- charge) of 5 days were 
obtained with scanning electron microscopy. Aggregates had approximately 100 µm 
diameter. Cells within aggregates gathered more round-like morphology like 
chondrocytes. Heavily produced extracellular matrix observed as dense fibrillar network 
filling around the cells is an indication of chondrogenic differentiation. Peptide 
amphiphile coating could also be distinguished and coating was well integrated with 
extracellular matrix produced by cells. These properties show biomimetic and 
biocompatible capabilities of peptide amphiphiles.  
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Figure 26. Aggregates observed with SEM at various scales
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1.3.2.7 Immunocytochemistry 
Expression of Collagen II which is a cartilage-specific marker was monitored with 
Collagen II antibody, in ATDC5 aggregates grown for 14 days. Aggregates at 14 days 
express Collagen II significantly whereas immunofluorescence relevant to Collagen II 
expression was not observed on ATDC5 cells grown on tissue culture plate for 14 days.  
 
   
 
            
  
 
 
 
 
 
 
 
 
Figure 27. Collagen II expression within an aggregate grown on Glu PA/Lys PA (-charge) (a) Col II
staining (b) Nuclei staining with TO-PRO (c) Merged image 
(a) (b) (c) 
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1.4 Conclusion  
Cartilage tissue is prone to damages via accidents and diseases like osteoarthritis and 
rheumatoid arthritis. Cartilage defects of critical size do not heal spontaneously. Extensive 
studies in various disciplines are carried on for regenerating cartilage. Models of 
chondrogenic differentiation are important for understanding development and 
regeneration of cartilage.  
In this chapter, a model system for studying chondrogenic differentiation which does not 
require the use of any bioactive factors was developed. In this model, cartilage formation 
at developmental stage was mimicked with peptide amphiphiles as scaffolds and ATDC5 
cells as chondrogenic progenitors.  
When ATDC5 cells were seeded on four combinations of peptide amphiphiles, 
proliferation of cells diminished and the cells aggregated. These aggregates became 
compact and got larger in area with time. Aggregation did not require insulin, but addition 
of insulin to the culture medium resulted in two times larger aggregates. Aggregates 
contained dense extracellular matrix, expressed collagen II, and were stained with 
Safranin-O similar to native cartilage tissue. A significant difference of GAG-PA which is 
designed as a mimetic model for sulfate bearing glycosaminoglycans could not be 
inferred in two- dimensional culture. However, GAG-PA+Glu-PA (- charge) scaffold 
resulted in an additional increase of aggregate numbers which may suggest proliferative 
role. GAG-PA+Glu-PA (neutral) scaffold on the other hand, provided rapid aggregation 
but aggregate growth was not as extensive as other scaffolds. 
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From these results we can infer that peptide amphiphiles can mimic extracellular matrix 
and act as reservoir for growth factors which take role in differentiation. Moreover, 
peptide amphiphiles are biocompatible in integrating with the native matrix.  
This model is convenient for studying several aspects of chondrogenic differentiation 
without supplementing any bioactive factors. Several stages of chondrogenic aggregation 
can be visualized within 18 days. Besides, this model can be employed before in vivo 
experiments to visualize the effects of drug and bioactive factor release. 
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CHAPTER 2 
 
MORPHOLOGICAL ANALYSIS OF VARIOUS TISSUES FROM 
LYNX-3 LACKING BAC TRANSGENIC MICE IN COMPARISON 
WITH WILD TYPE MICE  
 
2.1   Introduction 
Cholinergic system has evolved through time beginning from early ages and it exists 
within a large spectrum of life forms including simple and complex organisms [169]. 
Components of cholinergic system include choline-acetyl transferases, acetylcholine, 
nicotinic acetylcholine receptors, muscarinic acetylcholine receptors, and choline 
esterases. In humans and other mammals, nicotinic and muscarinic acetylcholine receptors 
play a central role in neuronal and non-neuronal regulatory mechanisms [170]. Neuronal 
nAChRs are involved in many brain processes like learning and memory, reward, and 
mood [171]. In non-neuronal tissues, nicotinic and muscarinic acetylcholine receptors are 
involved in development [172], wound healing [173], immune regulation [174], and 
angiogenesis [175].  
LY-6 superfamily is composed of cell surface proteins including lynx subfamily of 
proteins. Lynx1, a neuropeptide, is the first revealed member of lynx subfamily. Lynx2 is 
expressed within central nervous system similar to Lynx1 [176, 177]. 
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Lynx3 is a recently discovered member of LY6SF, and expressed in central nervous 
system as well as lungs, trachea, esophagus, forestomach, thymus, female reproductive 
organ [178].  
2.1.1 LY6 superfamily of genes/proteins   
Ly6 superfamily is composed of protein members with three finger domains containing 4-
5 S-S bonds. Some of the well-known members of the Ly6SF are ly6 genes, CD59, 
SLURP-1 and SLURP-2, E48 antigen, lynx1, and alpha neurotoxins such as alpha-
bungarotoxin which is an antagonist of nAChRs [179]. Protein members are expressed in 
a wide variety of mammalian cells, being involved in diverse tasks.  
Human CD59 gene is localized at chromosome region 11p13. It encodes 77 amino acid 
GPI anchored cell surface antigen detected by MEM43 and other antibodies. CD59 
prevents formation of membrane attack complex (MAC) assembly on the host cells by 
binding to C5b-8 and C5b-9, thus prohibiting the host cells from being lysed [180]. 
E48 (LY6-D) is a specific marker for normal, malign, and transient squamous cells [181]. 
It serves as a molecular marker for the detection of squamous cells within blood and bone 
marrow [182]. E48 was shown to be involved in the association of head and neck 
squamous cells with endothelial cells [183].  
SLURP-1 is a member of LY6SF without a GPI anchorage signal, in contrast to the most 
other members. It is an allosteric modulator of the keratinocytic α7 nicotinic acetylcholine 
receptors [184] which play role in the differentiation of the stratified squamous epithelium 
[185]. SLURP-1 was shown to have a proliferation suppressing effect at the same time 
promoting the expression of apoptotic enzymes and terminal differentiating markers 
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[186]. Mal de Meleda is an autosomal recessive disorder, characterized by mutations in 
the gene encoding SLURP-1 localized at 8q24.3 [187].  
SLURP-2 is another secreted cholinergic signaling protein mainly expressed in epithelial 
tissues. It is overexpressed in psoriasis vulgaris, a hyperproliferative skin disorder [188]. 
Unlike, SLURP-1 which prefers α7 nAChRs, SLURP-2 acts on α3 nAChR subtypes. 
Contrasting with the roles of SLURP-1, SLURP-2 was assigned roles of supporting 
proliferation, slowing down the differentiation and hindering apoptosis [189]. These two 
secreted proteins have recently been shown to function in protection of the cells from the 
cancer inducing activity of tobacco derived nitrosamines [190, 191]. 
Many of the Ly-6 genes are located in the telomeric region of chromosome 8 (i.e. 8q24) 
of human genome which is syntenic to a locus at chromosome 15 of mice genome. 
19q13.3 and 6p21.3 are two other regions at which the Ly-6 genes are likely to be found 
in human genome [192-194]. An SNP at the Ly-6 cluster locus at chromosome 8 was 
recently found to be associated with HIV susceptibility suggesting a role for Ly-6 genes in 
this region [195]. 
2.1.2   Lynx homologous genes 
Lynx1, the first unraveled member of lynx gene family is highly expressed in central 
nervous system and lungs. Forming stable complexes with nicotinic acetylcholine 
receptors (nAChR), Lynx1 alters the sensitivity of these receptors which contributes to an 
overall inhibitory effect. Sequence homology between snake venom neurotoxin and Ly6 
family of proteins as well as tertiary structural similarity had been elucidated without any 
common function between two relative protein subtypes being revealed except for lynx1. 
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Lynx1 shares primary and tertiary structure homology with snake venom neurotoxins 
which act as nAChR antagonists. Snake venom neurotoxins and lynx1, all have the ability 
to interact with nAChRs and modulate sensitivity of the receptors and the kinetics of ion 
channel gating. Unlike, neurotoxins which are soluble proteins, lynx1 is a GPI-anchored 
protein, and show its effect in membrane bound form. Chimerical constructs with GPI-
anchorage sequence of lynx1 and the soluble neurotoxin sequence were designed and 
these were used for obtaining membrane bound form of several neurotoxins. In membrane 
bound form, similar to lynx1, recombinant neurotoxins could still interact with the 
receptors and modulate their activity [196]. 
Immunohistochemistry experiments showed colocalization of Lynx1 expression with α4 
nAChRs within cortex, amygdala, habenula and substantia nigra in adult mice. Within 
cortex, amygdala, hippocampus and thalamic reticular nuclei, lynx1 colocalized with a7 
nAChRs [197].  
Lynx2, similar to Lynx1 is a neuromodulatory protein expressed in neuronal cell 
population. Lynx2 was specifically localized to anxiety-related brain areas. Since, higher 
levels of anxiety were observed for lynx2-KO mice, lynx2 was proposed to be a key 
element in anxiety-related behavioral mechanisms [176].  
Lynx1 and Lynx2 proteins are involved in the modulation of brain plasticity within 
critical period during adulthood. Lynx1 mRNA levels in adult visual cortex elevated after 
the critical period, while lynx2 levels decreased. Lynx1, also called as cholinergic brake, 
is considered to be limiting the brain plasticity [198]. 
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Lynx3 is also a modulator of nAChRs and is expressed in neurons and epithelia of a vast 
diversity of tissues. The tissues in which lynx3 is expressed include lungs, stomach, 
thymus, reproductive organs, spleen, and nasal cavity. Lynx1, lynx2 co-precipitated with 
α4β2, α4β4, α1β1γ and α7 nAChRs. Lynx3 co-precipitated α4β2, α4β4. All three 
homologues can modulate desensitization kinetics of α4β2 nAChRs (unpublished data).  
Lynx subfamily of genes also occurs in other species such as C. elegans, D. melanogester 
and non-venomous snakes. 
2.1.3   Acetylcholine receptors 
Acetylcholine is a simple molecule playing a central role in cell function (Figure 1). It 
was firstly recognized as a molecule involved in transmitting signals among nerves. 
Besides neurotransmission, acetylcholine functions widely among non-neuronal tissues as 
will be explained later.  
 
 
Figure 28. Chemical structure of acetylcholine, acetylcholine is an ester of acetic acid and N,N,N-
trimethylethanolammonium cation  
 
Acetylcholine is composed of AcetylCoA, a basic metabolite in Krebs cycle, and choline 
which is a quaternary amine which can be obtained from degradation of phospholipids of 
the cell membrane. Choline acetyl transferase enzyme is responsible for synthesizing 
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acetylcholine from two precursors. For humans, this enzyme is encoded by ChAT gene 
which was mapped to human chromosome 10. Expression of this enzyme is universal for 
every human tissue, while isoforms of the enzyme are observed for different tissues [170].  
Acetylcholine acts through binding acetylcholine receptors anchored within cellular 
membrane. This system is thought to have emerged early in the history of life as its 
components are present in bacteria, fungi, protozoa, sponge, and simple plants. An 
organism with evolutionary significance is Torpedo genus producing electricity through 
cholinergic activity [169, 170].  
Mammalian acetylcholine receptors are expressed by a wide diversity of cells within 
body. Two major types of acetylcholine receptors are mecanotrophic muscarinic 
acetylcholine receptors (mAChRs) and ionotrophic nicotinic acetylcholine receptors 
(nAChRs). Muscarinic acetylcholine receptors are G protein coupled receptors and 
intercellular pathways are induced as a result of interaction with G protein. Nicotinic 
acetylcholine receptors lead to cation (Na+, K+, Ca++) inflow through the membrane [199]. 
While both receptors are activated by acetylcholine, these receptors may be activated by 
chemicals specific to each type of acetylcholine receptor. In the case of mAChRs, a toxin 
from mushroom Amanita muscaria called muscarine is an activator and a toxin from 
Atropa belladona called atropine is an inhibitor. Muscarinic acetylcholine receptors have 
slower activation kinetics than nicotinic acetylcholine receptors with a response time of 
milliseconds to seconds [200].  
Nicotinic acetylcholine receptors are cationic receptor channels which can be activated in 
the presence of nicotine. Much of our knowledge about nAChRs was brought about with 
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studies on alpha-bungarotoxin, which is a snake venom that inhibit muscle type nAChRs. 
Alpha-bungarotoxin binds to nAChRs with an affinity which is about covalent bond 
strength. Making use of this high affinity, alpha-bungarotoxin conjugated columns were 
designed for isolation and purification of nAChRs [200-202]. The amino acid sequence of 
–NH2 terminal protein was identified after purification which enabled deciphering and 
cloning genes encoding nAChRs with reverse genetics methodologies. In a variety of 
mammalian cells, including muscle, skin, pancreas, lungs and neurons, nAChRs were 
reported to exist, having essential roles [200, 203].  
Much of the knowledge for nAChR structure was gained from the studies with Torpedo 
nAChR [204, 205]. Low abundance of the receptor within whole protein soup lead to 
difficulties in isolating and revealing the structure. Herein, the electric organ of Torpedo 
ray in which nAChRs are massively produced, served as a source for nAChRs, partly 
solving this problem [200].  
Nicotinic acetylcholine receptors are ligand gated channels belonging to Cys-loop 
receptor family. A pair of Cys-Cys bonds separated by 13 amino acids exists for this 
family of proteins at the extracellular portion of the protein. Other members of the family 
are 5-hydroxytryptamine type 3 (5-HT3) receptors, γ-aminobutyric acid type A (GABAA) 
and GABAC receptors, glycine receptors, and invertebrate glutamate and histidine 
receptors [200]. 
Nicotinic acetylcholine receptors are composed of five membrane spanning protein 
subunits arranged in a barrel like structure. Five subunits designated as 2 α subunits, β, δ 
and γ or ε, are made up of helices M1, M2, M3, and M4. M2 helices lie at the inner side 
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of the channel providing hydrophobic intercore for dehydration of the ions and passage of 
the ions through the pore. Acetylcholine interaction site is included within extracellular 
portion of acetylcholine α subunits [200, 206].  
Binding of acetylcholine leads to opening of the channel, whereas continuous induction 
with acetylcholine causes channel closure, which is called desensitization. Upon binding, 
conformational changes in acetylcholine binding site and M2 helices were reported [207]. 
As the channel opens, the diameter of the pore becomes 0.65 nm and allows the passage 
of positively charged ions, Na+ and K+. Some subunit compositions, may allow passage of 
Ca2+ ions through the membrane, in this way release of other neurotransmitters may be 
triggered [206, 208].  
In vertebrates, according to the site of nAChR expression, subunit composition and ratio 
may differ. At neuromuscular junctions, α1, β1, δ, and γ or ε subunits unite to form the 
receptors in 2:1:1:1 ratio. Nicotinic acetylcholine receptors expressed in neurons are also 
composed of five subunits involving nine subtypes of α known as α2, α3, α4, α5, α6, α7, 
α8, α9, α10 and six subtypes of β known as β2, β3, β4, β5, β6, β7 [209, 210].  
Acetylcholine activity was formerly known to be specific for nervous system. It has 
become evident, however, that acetylcholine receptors and ChAT (Choline-acetyl 
transferase) exist throughout the body within a diversity of cells indicating synthesis, 
storage, release of acetylcholine and reception of acetylcholine through receptors. The 
cholinergic system certainly has a particular importance for many important aspects of life 
at cellular level. Through acetylcholine receptors, cell cycle, differentiation, cell to cell 
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contact, migration and apoptosis are regulated within epithelial cells, endothelial cells, 
immune cells, mesothelial cells and mesenchymal cells [170].  
Acetylcholine is released with the help of organic cation transporters and acts in autocrine 
or paracrine manner [211, 212]. Acetylcholine transport through the bloodstream is 
strictly prevented via rapid degradation by esterases.  
One interesting example of how acetylcholine exerts its effects was demonstrated with 
keratinocytes which altered their morphology and lost cohesive properties when n-AChRs 
and m-AChRs were blocked with antagonists [213]. Similarly, bronchial epithelial cells 
became smaller, and each cell lost contact with neighbors when treated with antagonist 
[170, 214]  
During developmental stages, keratinocytes express specific combination of muscarinic 
acetylcholine receptor subtypes. In this way, control of biological outputs during stages of 
keratinocyte maturation as a result of acetylcholine reception can be managed [215].  
Acetylcholine was found to be expressed throughout the epithelium that lines the inner 
and outer surfaces of rat airway, gastrointestinal, reproductive and urinary tracts (bronchi, 
mouth, small and large intestine, gall bladder, vagina, skin and pulmonary pleura) [216]. 
Keratinocyte muscarinic and nicotinic acetylcholine receptors, act oppositely for Ca2+ 
intake from extracellular fluid. Simulation of the muscarinic and nicotinic receptors 
concurrently, maintains balanced Ca2+ concentration and metabolism [217].  
Simulation with acetylcholine is also key in mediating keratinocyte migration. M4 
mAChR -/- murine keratinocytes showed impaired migration, and inhibition of 
 
 
86 
 
keratinocytes with atropine had a similar effect. Besides, activation of M4 with muscarine 
resulted in increased migration of M3 mAChR -/- keratinocytes, which exhibited 
increased migration distance, showing adverse effect to M4 type receptors. Wound 
healing response, in parallel to migration of keratinocytes, was improved in M3−/− but 
weakened in M4−/− knockout mice  [217,  218].  Moreover, hair follicle cycle was 
disturbed in M4−/− knockout mice [219]. 
Human and rat airway cells, likewise, express mAChRs. nAChRs and mAChRs are 
effected by ACh [216, 220]. Nicotinic acetylcholine receptors were shown to be involved 
in migration of bronchial epithelium cells and wound healing of lung epithelium [221]. 
In intestine epithelial cells, cholinergic system is involved in directional fluid movement 
within intestinal tract by regulating chlorine secretion [222]. Similarly, ion and fluid 
movements are modulated by acetylcholine in mucosal and glandular epithelial cells [223, 
224]. 
Acetylcholine receptors also have role in attracting immune cells towards airway 
epithelial barrier and stimulating mucus activity. Acetylcholine may also alter immune 
responses. Activation of α7 with acetylcholine inhibits the release of pro-inflammatory 
factors such as tumor necrosis factor or IL1-β from immune cells. The process was named 
as cholinergic anti-inflammatory pathway [224, 225]. 
2.2    Experimental Section 
Morphologies of different tissues for Lynx3 KO mice and WT mice were investigated. 
Cloning of KO constructs was performed by Dr. Ayşe Begüm Tekinay with C57B16 
genomic DNA containing bacterial artificial chromosomes from Research Genetics, and 
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10 kb genomic DNA containing clones from Open BioSystems as template. Histological 
sectioning and Hematoxylene Eosin staining were also done by Dr. Ayşe Begüm Tekinay. 
Briefly, mice were perfused with PBS, then perfusion solution containing 1.4% Na-
cacodylate, paraformaldehyde, 4% sucrose followed by perfusion wash solution 
containing 0.034% Na-cacodylate, 0.023% CaCl2, 0.8% sucrose, 0.8% NaCl and 0.4% 
dextrose. Tissues were sectioned with a microtome. Tissue sections were analyzed with 
light field microscopy at 10x and 40x magnifications.  
2.3    Results and Discussion 
2.3.1 Trachea 
It was shown that lynx3 is heavily expressed within the pseudostratified ciliated columnar 
epithelium lining of upper and lower respiratory tract. Covering the inner surfaces of 
nasal cavities and trachea, this type of epithelium is basically composed of ciliated cells 
and goblet cells which together act to protect lungs from foreign materials brought by air. 
Goblet cells secrete mucus, a sticky material rich in glycoproteins, which traps airborne 
particles and microorganisms. Ciliated cells, repel the trapped particles outwards, by 
coordinated movements of cilia on their apical surfaces. Structurally resistant to wear and 
abrasion, the epithelial layer also provides mechanical protection from airflow [226, 227]. 
A third type of cell, representing 3% of the epithelial layer exist and is called “brush cell”, 
a name coming from brushy appearance of blunt and short extensions present at the apical 
membranes of the cells. Function of brush cells has been uncertain for a long time, but 
these cells have been considered to be chemosensors [228].  
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It is almost impossible to distinguish between epithelial cell phenotypes mentioned above 
from trachea section images of wild type mice and lynx3 BAC transgenic mice displayed 
at Figure 1. Cilia structures however can be seen and these are present for both wild type 
and lynx3 deficient mice. Wild type mice and lynx3 deficient mice are similar in 
morphologies of tracheal epithelium as well as surrounding cartilage and smooth muscle 
layers and overall trachea. Retention of morphologies other than epithelium is an expected 
result since lynx3 expression is limited to the epithelium. Also, lynx3 is related with the 
cholinergic system which acts mostly atocrine/paracrine.  
Acetylcholine is important in epithelial proliferation, wound healing mechanisms [170, 
214]. Within trachea, acetylcholine is also involved in regulation of cilia movement, 
recruitment of immune cells for protection from infection. Recently, brush cells were 
reported to express ChAT enzyme and vesicular acetylcholine transporters and some of 
these cells are in direct contact with vagal nerve fibers and their role for regulation of 
respiratory rate was discovered [228].  
Any significant difference in epithelial proliferation is not observed between wild type 
and lynx3 deficient BAC transgenic mice. Moreover, any inflammatory conditions or 
abnormalities cannot be seen in KO and WT mice.  
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Figure 29. Hematoxyline & Eosin stained sections of cartilaginous airways of various phenotypes. From left to right: WT female, lynx3 KO female, WT male, KO male. Top: 10x 
objective scale bar: 100 µm, Bottom: 40x objective scale bar: 50um   
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2.3.2 Lungs 
Tracheal expression of lynx3 is followed by lynx3 expression within bronchi and 
bronchioli. In bronchi, ciliated simple columnar epithelium cells and in bronchioli 
cuboidal epithelium cells express lynx3. As in tracheal epithelium, any significant 
difference in morphology between wild type and lynx3-/- BAC transgenic mice was not 
observed. Any inflammatory condition or physiological abnormality was not observed. 
Cholinergic stimulation is mostly associated with cell-cell adhesion, proliferation, 
migration and wound healing for epithelial cells within lungs. Treatment of bronchial 
cells with ACh receptor antagonists of strong affinity resulted in cell shrinkage and loss of 
contact between neighbor cells. Absence of lynx3 inhibition of ACh receptors does not 
have an apparent impact on these mentioned properties, at least during early 
developmental stages [170, 214, 229]. 
Functional redundancy may have served as a means to maintain wild type morphology in 
lynx3-/- BAC transgenic mice. Expression of lynx1 which is a homologue with similar 
function in bronchial epithelium has been revealed [230]. Functionally similar proteins 
like lynx1, might be regulated in a way to compensate for the insufficiency caused by 
lynx3 deficiency.  
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Figure 30. Hematoxyline & Eosin stained sections of lungs for lynx3 expressing and lynx3 deficient mice. From left to right: WT female, lynx3 KO female, WT male, KO male. Top: 
10x objective scale bar:100 µm, Bottom: 40x objective scale bar: 50 µm   
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2.3.3 Esophagus 
In esophagus, lynx3 is expressed in stratified squamous epithelium lining the inner cavity. 
Esophageal mucosa of lynx3 BAC transgenic male mouse (Figure 32., top right), was 
disrupted at some regions and is thinner than others. Larger esophageal diameters for 
lynx3 BAC transgenic mice than for wild type mice might be due to different sectioning 
positions or dilation. In BAC transgenic mice esophagus posed asymmetrically. There 
might be possible differences in smooth mucle contractile properties. Mucosal breaks and 
circumferential asymmetry might also be associated with esophagitis and GERD 
(Gastroesophageal reflux disease) [231].  
In oral keratinocytes blocking of nicotinic acetylcholine receptors resulted in loss of cell-
cell contact and cell motility. Furthermore, stimulation of nAChRs by tobacco derived 
nitrosamines lead to changes in patways which contribute to cancer. Tobacco smoking is 
an important factor in development of oral and esophageal cancer. Nicotinic acetylcholine 
receptor subtypes present in esophageal mucosa are α3, α5, α7 and β2 similar to oral 
keratinocytes [232].  
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Figure 31. Hematoxyline & Eosin stained sections of esophagus for lynx3 expressing and lynx3 deficient mice. From left to right: WT female, lynx3 KO female, WT male, KO male. 
Top: 10x objective scale bar:100 µm, Bottom: 40x objective scale bar: 50 µm 
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2.3.4 Stomach 
Lynx3 expression was observed within non glandular part of stomach called forestomach. 
Forestomach is adjacent to esophagus and stratified squamous epithelium lines inside. 
Mucosal ridge which separates forestomach from glandular stomach can be seen in 
micrographs given in Figure 5. Epithelium, connective tissue, circular and longitudinal 
smooth muscles are well arranged in all mice. Moreover any severe morphological 
abnormality was not conspicuous. Within the forestomaches of lynx3-/- BAC transgenic 
mice, however, the average lengths of the mucosal folds were apparently reduced with 
respect to forestomaches of wild type mice.  
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Figure 32. Hematoxyline & Eosin stained sections of esophagus for lynx3 expressing and lynx3 deficient mice. From left to right: WT female, lynx3 KO female, WT male, KO male. 
Top: 10x objective scale bar:100 µm, Bottom: 40x objective scale bar: 50 µm 
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2.3.5 Thymus 
In thymus, lynx3 is expressed within scattered epithelial cells and lymphocytes. Any 
significant difference between thymic morphologies of lynx3 BAC transgenic mice and 
wild type mice cannot be observed (Figure 6).  
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Figure 33. Hematoxyline & Eosin stained sections of thymus for lynx3 expressing and lynx3 deficient mice. From left to right: WT female, lynx3 KO female, WT male, KO male. 
Top: 10x objective scale bar:100 µm, Bottom: 40x objective scale bar: 50 µm 
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2.3.6 Female reproductive organ 
Lynx3 expression in female reproductive organ is localized to squamous stratified 
epithelium. In wild type female mouse, reproductive tract with two different 
morphologies were observed. One of them has within bulky mucosa and the other has 
thinner mucosa. In lynx3-/- BAC transgenic mice the reproductive organ with the bulky 
epithelial layer could not be observed.  
In lynx3 BAC transgenic mice, foreign bodies were present inside the epithelial layer, 
which are likely to be immune cells. This is a possible indication of activated immunity 
around epithelial cells of the female reproductive organ in lynx3 deficient mice.  
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Figure 34. Hematoxyline & Eosin stained sections of female reproductive organ for lynx3 expressing and lynx3 deficient mice. From left to right: WT female, WT female, KO female, 
KO female. Top: 10x objective scale bar:100 µm, Bottom: 40x objective scale bar: 50 µm 
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2.4   Conclusion 
In this study, various tissues of wild type and lynx3 deficient mice were histologically 
compared with a focus on epithelial tissue.  
In respiratory tract, pseudostratified columnar epithelium of trachea, ciliated columnar 
epithelia of lungs were investigated. Any distinctive features between wild type mice and 
lynx 3 deficient mice could not be observed.  
In alimentary tract, stratified squamous epithelium of esophagus and forestomach was 
investigated. Esophageal epithelia were similar for both WT and transgenic mice. 
Esophagi of transgenic mice were more asymmetric than esophagi of WT mice. 
Moreover, non-glandular stomachs of lynx3 BAC transgenic mice had smaller mucosal 
curvature. 
Scattered epithelium cells and lymphocytes within thymuses of all mice had similar 
morphology.  
Non-keratinizing stratified epithelia of female reproductive organs of lynx3 deficient mice 
contained foreign bodies which are possibly immune cells. In wild type mouse, these 
bodies were not observed.  
Moving from these results more detailed investigation of these should be done in order to 
better understand the function of lynx3.  
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CHAPTER 3 
 
 CHARACTERIZATION OF PEPTIDE AMPHIPHILES AS DNA 
DELIVERY AGENTS 
 
3.1 Introduction 
Effective transportation of DNA into the cells is an important step towards accomplishing 
gene therapy. Naked DNA is prone to degradation by intracellular or extracellular 
enzymes and it can barely pass the plasma membrane [233].  
Viruses are natural cargo delivery systems which have been specialized in loading their 
genetic material within a variety of cells in a highly efficient way. Viral components may 
be effective as DNA delivery agents, however these are asscoiated with certain health 
risks such as toxicity, and inflammation [234]. Non-viral delivery systems have also been 
promising in gene delivery, and some of them became commonly used in transfection 
protocols. Cationic lipids and polymers are two main groups of non-viral-delivery agents.  
3.1.1  Cell Penetrating Peptides 
Basic proteins like histones have been known for a long time for crossing over 
membranes with relative ease. These proteins also enhance the passage of other molecules 
to which they are associated [235]. 
Knowledge about ability of proteins with high basic amino acid content to easily 
translocate into cytoplasm inspired scientists to study protein chemistry to develop novel 
non-viral vectors [236-238]. As a result of these studies, small protein-like molecules 
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commonly known as cell penetrating peptides have emerged. These molecules can 
spontaneously bind DNA to form compact complexes and they have been drawing a lot of 
attention.  
Cell penetrating peptides can cross the plasma membrane and transfer genetic material 
into the cell which is attached to them via covalent or physical bonds [239]. Peptides can 
be designed and functionalized further to be involved in multiple roles like stabilizing 
DNA in body fluids, targeting cell types and receptors, and facilitating escape from 
lysosomal degradation [240]. Cationic peptides are composed largely of basic amino acids 
including lysine, arginine and histidine.  
Poly-L-Lysine is a well studied DNA carrier. This polypeptide enhances internalization of 
DNA to some extent but it exerts toxic properties which increases with growing chain 
length and requires additional agents for providing endosomal escape and release within 
the cytoplasm [241-243]. Moreover, high polydispersity of poly-L-Lysine products 
decreases control over further chemical processes. Small peptides with repeated lysine 
residues can be synthesized at precise molecular weights. Peptides are also advantageous 
as they are less toxic than high molecular weight polypeptides [244]. Cys-Trp-Lys(n) 
peptides with at least 13 lysine residues can form stable and compact peptide-DNA 
complexes whereas peptides having less than 8 lysine residues form unstable large 
condensates of micron size [245].  
Cationic peptides with sequence YKAK(n)WK varying in the number of Lys residues 
were tested for efficiency in forming stable DNA complexes and in gene transfection. 
YKAK8WK molecules made stable complexes with DNA, however, supplementing with 
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GLFRALLRLLRSWRLLLRA peptide, which was designed for facilitating endosomal 
escape, was required to achieve efficient transfer and expression of genes [246].  
Polylysine peptides are capable of entering into the cell however these are not very good 
at penetrating endosomal membranes, which they become encapsulated within. Inclusion 
of histidine residues were shown to be useful in mediating endosomal escape of peptide-
DNA complexes. This effect is probably caused by buffering capacity of histidine 
imidazole rings in slightly acidic interior environment of endosomes [247]. A histidine 
rich peptide H5WYG was reported to cross cellular membranes after an incubation for 15 
minutes and remained intact within serum without losing activity [248].  
Homomeric peptides composed of nine basic amino acid residues were evaluated for their 
ability to enter cytosol. Peptides were covalently attached to fluorescent dyes for tracking. 
Nona-arginine peptides were found to be better at passing membrane than nonapeptides 
composed of lysine, histidine and ornithine [249]. 
Epitopes derived from proteins of viral coats can promote endosomal escape or nuclear 
transportation. An amphipatic part within TAT protein of human immunodeficiency virus 
1, HIV-1, which is 9 amino acids long can bind DNA stably and help its internalization. 
Using TAT peptides, transfection efficiency reached to 6-8 times higher levels with 
respect to control peptides [250].  
Penetratine derived from the transcription factor Antennapedia of Drosophila 
melanogaester is another well known peptide able to translocate plasma membrane. 
Penetratine has been succesful in various studies in delivering nucleic acids [251].  
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Beside high basic content, high hydrophobic moment with alpha helix forming propensity 
is also seen among peptides with cell penetrating ability. An example to such peptides 
might be transportan, composed of 26 amino acids in which active part of a ligand called 
galanin and a 14 amino acids long wasp venom toxin are combined with a lysine residue. 
Transportan molecules could rapidly internalize within a variety of cell types and 
accumulated in nucleoli [252].  
In a study, four different cell penetrating peptides were compared in delivering peptide 
cargo and in disrupting cellular membrane. Peptides with high hydrophobic moments and 
low basic content, namely transportan and MAP were found to be more efficient cargo 
deliverers and effective at lower doses in disrupting the cellular membrane compared to 
peptides with high basic content which are TAT and penetratin [253]. A directly 
proportional relation between amount of membrane leakage and hydrophobicity moment 
is apparent [253]. Proteasomes are intercellular entities which are considered to be 
possibly degradating peptide-DNA complexes which might decrease efficiency. In the 
sequence of Epstein Barr virus nuclear antigen I protein, a block of 238 amino acids 
composed purely of reoccuring Gly-Ala subsequences can prevent the protein from being 
lysed by proteasomes. In this regard, peptides with Gly-Ala dipeptide repeats were 
designed to block proteasomes. Elevated gene expression observed as a result of 
incorporation of Gly-Ala repeats within cell penetrating peptide designs proves usefulness 
of this particular motif [254].  
Peptides may also be designed to include signals to import DNA within the nucleus to 
allow for transcription to proceed. Signals for nuclear localization can be extracted from 
viruses and nuclear proteins. Seven aminoacid-peptide PKKKRKV, derived from large 
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tumor antigen of simian virus 40 accelerated the transport of DNA to the nucleus so that 
DNA accumulated in 100 times shorter period [255]. Pentapeptide KRPRP is another 
minimal nuclear localization signal derived from adenovirus E1a protein [256]. Peptides 
PAAKRVKLD, RQRRNELKRSP are derived from human c-myc protein nuclear 
localization signal [257].  
3.1.2  Peptide amphiphiles in gene delivery 
Amphiphilicity is considered to be important in interaction of peptides with cell 
membranes. Many peptides of viral origin that lead to fusion of lipid bilayers are 
amphiphilic, such as influenza hemaglutinin derived GLFEAIAEFIEGGWEGLIEG and 
GLFKAIAKFIKGGWKGLIKG [258]. In de novo design of peptides for cellular 
internalization of nucleic acid loads, some researchers focused on micelle forming or self 
assembling amphiphilic peptide molecules. 
RV peptides assemble into micellar structures due to hydrophilic arginine residues and 
hydrophobic valine residues in their chemical structure. Four different RV peptides were 
synthesized varying in number of arginine residues, R1V6, R2V6, R3V6 and R4V6. Packing 
DNA to compose micellar DNA-peptide condensates, peptides could efficiently deliver 
plasmid DNA into HEK293 cells. R3V6 and R4V6 formed more stable complexes and 
could deliver DNA at lower quantities than R2V6 and R1V6. In contrast to 
polyethyleneimine and poly-L-lysine, RV peptides did not show cytotoxicity, which is 
thought to be due to low charge density per molecule [259]. 
Molecules that contain hydrophobic alkyl chain conjugated to N terminal of water soluble 
peptides are frequently called as peptide amphiphiles. Peptide amphiphiles can assemble 
into various micellar structures like vesicles and nanofibers. Fibrillar scaffolds assembled 
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from peptide amphiphiles have been frequently used in studies of regenerative medicine 
for culturing cells. Peptide amphiphiles also hold potential for nucleic acid internalization 
applications, since the presence of hydrophobic core may improve interaction with plasma 
membrane [260, 261]. 
DNA-binding peptide amhiphile, bZIP, bearing the sequence from yeast transcription 
factor GCN4 as DNA binding fragment was synthesized with solid phase peptide 
synthesis. The sequence taken from GCN4 is 30 amino acids long and in the nucleus this 
block folds into alpha helices to further form coiled coils of leucine zipper motifs. 
Attaching an alkyl tail to GCN4 was reported to enhance formation of alpha helices and 
improved the orientation of peptides to better resemble its original conformation. These 
peptide amphiphiles formed lamellar assemblies with DNA. The assemblies, however, 
need further stabilization like polymerization of hydrophobic alkyl chains. [262]. 
Peptide nucleic acid-peptide amphiphile molecules can constitute nanofibers and can 
strongly bind oligonucleotides in a sequence specific manner with oligonucleotides 
combined within peptide amphiphile structure. These molecules might be useful in RNA 
interference applications, which need further investigation [263].  
In another study, fatty acids were conjugated to cell penetrating peptides in order to 
investigate the influence of hydrophobic moiety to transfection efficiency. Transfection 
efficiency, improved significantly, reaching almost the same levels with lipofectamine 
when stearic acid was attached to N termini of TAT, FHV and octaarginine peptides 
[261]. Incorporation of lauryl and cholesteryl moieties to octaarginine also improved 
transfection efficiency [261]. 
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In this study, peptide amphiphiles with cationic amino acid groups were synthesized. 
Ability of peptide amphiphiles and their combinations to stabilize DNA was investigated. 
Primary studies for evaluating transfection efficiency of molecules were performed.  
3.2  Materials and Methods 
3.2.1 Materials 
Materials used for peptide amphiphile synthesis were the same as described in the first 
chapter. Plasmid-DNA used in this study is pEGFP-N2. 
3.2.2 Design and Synthesis of Peptide Amphiphiles 
Three peptide amphiphile molecules were designed and synthesized for this study. Each 
peptide amphiphile had an alkyl tail with 12 carbons, followed by a beta sheet forming 
sequence ‘VVAG’, similar with the peptide amphiphiles described in Chapter 1. Peptide 
ampiphiles used in the study, are named according to the positively charged amino acid 
residues at C termini. Lysine, lysine-arginine and histidine are charged amino acids found 
at the C termini of Lys-PA, LysArg-PA and His-PA respectively. Based on the ability of 
peptide amphiphiles to form nanofibers, we thought that peptide amphiphiles can 
condense DNA and form large arrays of positively charged residues which were shown to 
be effective in gene delivery. In this way, peptide amphiphile nanofibers can serve as 
convenient platforms for gene delivery with relatively high efficiency and low toxicity. 
Chemical structures of peptide amphiphiles used in this study are shown in Figure 36.  
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Figure 35. Chemical structures of peptide amphiphiles (a) His-PA, (b) Lys-PA, (c) LysArg-PA 
(a) 
(b) 
(c) 
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Peptide amphiphiles were synthesized on 0.25 or 0.5 mmole scale with standard solid 
phase Fmoc chemistry on automated peptide synthesizer. Rink Amide MBHA resin was 
used as solid support. Fmoc groups were cleaved by treating the solid phase with 20% 
piperidine in DMF for a period of 20 minutes. Fmoc protected amino acids were dissolved 
in 10 ml DMF and activated with O-Benzotriazole-N,N,N’,N’-tetramethyluronium-
hexafluoro-phosphate (HBTU), and of N-ethyl-diisopropylamine (DIEA) in an For the 
purpose of blocking unreacted ends, resin was treated with 10% acetic anhydride for 30 
minutes after each coupling. After coupling all Fmoc protected amino acids by applying 
the steps mentioned above, alkyl tail was attached following the same protocol, but using 
lauric acid instead of Fmoc protected amino acid. 
Fully grown peptide amphiphiles were cleaved from resin, and side chain protective 
groups of functional groups were removed in a cleavage step for 2 hours with 
trifluoroacetic acid (TFA): triisopropylsilane (TIS): water at the ratio 95:2.5:2.5. Solution 
containing the cleavage products was collected at a round bottom flask and resin was 
washed several times with DCM. DCM was removed, and TFA was removed to a large 
extent with rotary-evaporation. Cleavage solution containing peptide amphiphile was 
triturated by adding ice-cold diethylether into the solution which was left overnight at -20 
°C. Diethylether was decanted after centrifugation at 8000 rpm for 15 minutes. Product 
was dissolved in ddH2O, frozen at -80 °C and freeze-dried at -50 °C for two days. Peptide 
amphiphiles were obtained in the form of powder.  
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3.2.3 LC-MS 
Molecular mass and purity of peptide amphiphiles were confirmed with Agilent 6530-
1200 Q-TOF LC-MS equipped with ESI-MS. Purity by peptide content was monitored at 
220 nm. Zorbax Extend-C18 21.2 x 150 mm column was used. A: 0.1 % trifluoroacetic 
acid in water and B: 0.1% trifluoroacetic acid in acetonitrile gradient was used.  
3.2.4 Biuret test 
A standard curve is obtained from serial dilution of BSA solutions in the concentration 
range of 1 mg/ml-10 mg/ml. For obtaining measurements, 150 µl Biuret reagent was 
added on 50 µl of peptide amphiphile or BSA and incubated for ten minutes at room 
temperature. Absorbance at 545 nm was recorded for each measurement. Concentrations 
of peptide amphiphile solutions were estimated with respect to standard curve.  
3.2.5 Gel retardation assay 
Gel retardation assay was performed by running an agarose gel loaded with PA-DNA 
complexes and naked DNA and visualizing the extent of retardation caused by peptide 
amphiphiles. In the first experiment, fixed amount of DNA was mixed with peptide 
amphiphiles in a way that positive to negative (Z+/Z-) charge ratio for each peptide 
amphiphile-DNA mixture varied between 0.25:1 and 2:1. Mixtures were incubated at 
room temperature for 45 minutes. Incubated samples and plasmid DNA with loading dye 
were loaded to wells of a 1% agarose gel with EtBr. 80 mV was applied for an hour. 
Bands were visualized by UV illumination with a gel imaging system. 
In a second experiment peptide amphiphile-DNA mixtures obtained at 2:1 (+/-) charge 
ratios were prepared for following formulations: His-PA/DNA, LysArg-PA/DNA, Lys-
PA/DNA, Lys-PA+His-PA/DNA, LysArg-PA+His-PA/DNA. Mixtures were incubate for 
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30 minutes at room temperature. Incubated samples and plasmid DNA with loading dye 
were loaded to wells of a 1.5% agarose gel . 100 mV was applied for an hour. Bands were 
visualized by UV illumination with a gel imaging system. 
3.2.6 Circular Dichroism 
Circular Dichroism study was performed with J-815 JASCO spectrophotometer. All 
spectra were obtained at a wavelength interval of 190-300 nm. Spectra were obtained at a 
digital integration time of 4 s, bandwidth of 1 nm, and data pitch of 0.1 nm. Three 
subsequent spectra were averaged for each sample. Quartz cuvettes with 2 mm 
pathlengths were used for measurements. According to the following formula, ellipticity 
was converted to molar ellipticity with the unit degree cm2 mol-1.  
 
[θ]:Molar ellipticity, θ:Ellipticity in degrees C:Concentration in M l:length in cm 
3.2.7 In vitro transfection  
PA-DNA complexes were tested in vitro for their EGFP gene transfection efficiency. 
Peptide amphiphile-DNA mixtures were incubated for 30 minutes at room temperature 
and then added dropwise on MCF7 cells seeded on 24-well plates at a cell density of 
15000 cells/well. Cultured cells were monitored every 24 hours. Fluorescence emmission 
of cells indicated EGFP protein expression as a result of transfected DNA. In vitro studies 
were carried by Murat Kılınç.  
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3.3 Results and Discussion 
3.3.1 Characterization of peptide amphiphile-DNA complexes 
Agarose gel electrophoresis was performed to evaluate stability of peptide amphiphile-
DNA complexes prepared at different positive to negative charge ratios. The results 
clearly showed that DNA was retarded in the presence of peptide amphiphiles, with more 
prominent retardation at higher positive to negative charge ratio (Z+/Z-). For Lys-PA and 
LysArg-PA, DNA partially migrated when the Z+/Z- ratios are 0.5:1 and 0.25:1 (i.e. when 
there is excess negative charge). When this ratio is equal to or greater than 1:1 DNA is 
fully retarded.  
In general, data obtained from gel retardation assays are assessed in two different aspects. 
First, DNA which is well stabilized by complexing agent, deprives of its motility and 
don’t migrate when an electric field is applied. Unstable DNA which can escape 
positively charged molecules can migrate without hindrance causing occurrence of a band 
in the proximity of naked DNA. Stability of any complex of DNA can be assessed by the 
amount of DNA stayed in well and amount of migrated DNA; less migration of DNA 
accounting to more stable DNA complexes [264, 265].  
In another aspect, in some studies DNA-peptide complexes tend to fluoresce less with 
Ethidium Bromide leading to fader bands on the gel. This might be through quenching of 
EtBr [266]. Failure of EtBr to diffuse effectively within large aggregates might also be a 
possible reason. Partially diminished bands observed for PA-DNA samples may also be 
showing formation of stable complexes.  
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Figure 36. Agarose gel electrophoresis of peptide amphiphile-DNA 
complexes at various charge ratios and naked DNA  
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Circular dichroism spectra of peptide amphiphile-DNA complexes were recorded in far 
UV region in order to assess the chiral morphology of PA-DNA complexes, as well as 
effect of time and Z+/Z- charge ratio on the structure.  
For investigating the effect of charge ratio, varying concentrations of positively charged 
peptide amphiphiles were used in forming complexes without changing the concentration 
of DNA. In order to know whether the concentration of the peptide amphiphiles used in 
this study influences circular dichroic features, spectra obtained for different 
concentrations of each peptide amphiphile were compared. As a result, CD spectra 
normalized to peptide amphiphile did not change or changed slightly between used 
concentrations.  
Mixing of plasmid DNA with one of positively charged peptide amphiphiles at 2:1 Z+/Z- 
charge ratio resulted in intensified positive signal which is near 200 nm. This change in 
signal is more significant when plasmid-DNA mixture was incubated for one hour. 
Figure 37. Agarose gel electrophoresis of several peptide amphiphile-DNA 
complexes at 2:1 positive to negative charge ratio
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Intensification of 200 nm signal was also observed at the charge ratio 4:1 (Z+/Z-) after 
one hour incubation, however, difference was less pronounced when compared to 2:1 
(Z+/Z-) samples.  
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Figure 38. Circular Dichroism spectra of peptide amphiphiles at 
changing molar concentrations  
 
 
117 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 39. Circular Dichroism of peptide amphiphile-DNA complexes 
at 2:1 positive to negative charge ratio (Z+/Z-)  
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Figure 40. Circular Dichroism of peptide amphiphile-DNA 
complexes at 4:1 positive to negative charge ratio (Z+/Z-) 
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 Figure 39. Circular Dichroism of peptide amphiphile-DNA 
complexes at 10:1 positive to negative charge ratio (Z+/Z-)
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 Figure 40. Circular Dichroism of peptide amphiphile-DNA 
complexes at 20:1 positive to negative charge ratio (Z+/Z-)
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3.3.2 In vitro transfection 
Transfection efficiencies of PA complexes were investigated by monitoring fluorescence 
led by EGFP gene expressed as a result of successful gene delivery. After two days, cells 
incubated with His-PA/DNA and His-PA+Lys-PA/DNA complexes emitted green 
fluorescence wherease cells incubated with Lys-PA/DNA, LysArg-PA/DNA complexes 
lacked fluorescence. Little fluorescence was observed in the case of LysArg-PA+His-
PA/DNA complex. On the other hand, incubation of cells with only naked DNA was 
sufficient for successful transfection.  
 
 
 
 
 
 
 
 
 
 
(a) (b) 
(c) (d) 
Figure 41. Transfected MCF7 cells with plasmid DNA-peptide amphiphile complexes and 
naked DNA on day 2. Cells were exposed to (a) His-PA/DNA, (b) Lys-PA+His-PA/DNA, 
(c) LysArg-PA+His-PA/DNA, (d) DNA .
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Interestingly, complexes which were inferred to be more stable according to gel 
retardation assay seem to fail delivery of the gene, besides leading to inferior results 
compared to naked DNA. Less stable complexes formed by His-PA and mixture of His-
PA with Lys-PA, LysArg/PA were able to transfect the cells but at similar efficiencies 
with naked DNA. An interpretation of this might have been facilitation of gene expression 
in the presence of His-PA due to endosomal escape provided by His-PA. However, a 
comparable amount of transfected cells in the presence of uncomplexed DNA refer to lack 
of any contribution of His-PA in increasing transfection efficiency. Apparently, there is an 
inverse relation between stable complex forming and transfection efficiency among tested 
peptide amphiphiles. This is contrary with results of several studies in which more stable 
complexes provide better transfection. The interactions with negatively charged 
polyphosphate backbone of DNA form the basis of stable complex formation and the 
same interactions formed with medium contents like phosphate molecules might be 
leading to neutralization and consequent lose of activity for peptide amphiphiles. 
Formation of local gels was observed for Lys-PA/DNA and LysArg-PA/DNA complexes 
when these were mixed with DMEM. This might be causing DNA to become entrapped 
and not delivered within the cell resulting in absence of transfection.  
3.3.3 Conclusion  
Cell penetrating peptides are molecular tools capable of packing DNA in compact 
packages and delivering DNA within the cell and increasing the possibility of gene 
expression to a great extent. Amphiphilic properties are gaining more attention in 
peptides’ ability to deliver negatively charged molecules inside the cells. In this chapter, 
we devised anmphiphilic peptide systems which could condense DNA and make it more 
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stable and help its pass the cell membrane in order to be expressed inside the cell. Three 
different peptide amphiphiles were produced for evaluating particular merits of different 
cationic aminoacids. Peptide amphiphiles successfully stabilized DNA which is possibly 
due to neutralization and beta sheet formation. However, peptide amphiphiles were not 
efficient in transfecting DNA as tested in vitro and the cause of low efficiency is not very 
clear.  
In the future, it is essential to investigate why peptide amphiphiles were not efficient 
DNA transporters although they stabilized DNA effectively. Different in vitro transfection 
protocols might be tried in order to see whether interaction of peptide amphiphiles with 
the medium components create disturbance in complex arriving the cell. Peptide 
amphiphile oligonucleotide complexes may be assembled and may be tracked via a 
fluorescent reporter directly attached on oligonucleotide. Moreover, different peptide 
amphiphiles can be designed and synthesized which are better at buffering the ionic 
constituents of the media which would avoid formation of unwanted aggregates and also 
help endosomal escape.  
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